{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:54:38Z","timestamp":1790650478296,"version":"4.1.0"},"reference-count":280,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Creutzfeldt-Jakob Disease Foundation, Inc."},{"DOI":"10.13039\/501100017519","name":"Werner-Otto-Stiftung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017519","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK1459"],"award-info":[{"award-number":["GRK1459"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK1459"],"award-info":[{"award-number":["GRK1459"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 877 project A12"],"award-info":[{"award-number":["CRC 877 project A12"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Res"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prion protein (PrP) is a broadly expressed glycoprotein linked with a multitude of (suggested) biological and pathological implications. Some of these roles seem to be due to constitutively generated proteolytic fragments of the protein. Among them is a soluble PrP form, which is released from the surface of neurons and other cell types by action of the metalloprotease ADAM10 in a process termed \u2018shedding\u2019. The latter aspect is the focus of this review, which aims to provide a comprehensive overview on (i) the relevance of proteolytic processing in regulating cellular PrP functions, (ii) currently described involvement of shed PrP in neurodegenerative diseases (including prion diseases and Alzheimer\u2019s disease), (iii) shed PrP\u2019s expected roles in intercellular communication in many more (patho)physiological conditions (such as stroke, cancer or immune responses), (iv) and the need for improved research tools in respective (future) studies. Deeper mechanistic insight into roles played by PrP shedding and its resulting fragment may pave the way for improved diagnostics and future therapeutic approaches in diseases of the brain and beyond.<\/jats:p>","DOI":"10.1007\/s00441-022-03582-4","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T05:02:47Z","timestamp":1643259767000},"page":"215-234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein"],"prefix":"10.1007","volume":"392","author":[{"given":"Behnam","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feizhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Matamoros-Angles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9439-6533","authenticated-orcid":false,"given":"Hermann Clemens","family":"Altmeppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"3582_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-019-02085-x","volume":"139","author":"P Aguilar-Calvo","year":"2020","unstructured":"Aguilar-Calvo P, Sevillano AM, Bapat J, Soldau K, Sandoval DR, Altmeppen HC, Linsenmeier L, Pizzo DP, Geschwind MD, Sanchez H, Appleby BS, Cohen ML, Safar JG, Edland SD, Glatzel M, Nilsson KPR, Esko JD, Sigurdson CJ (2020) Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions. Acta Neuropathol 139:527\u2013546","journal-title":"Acta Neuropathol"},{"key":"3582_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev.neuro.31.060407.125620","volume":"31","author":"A Aguzzi","year":"2008","unstructured":"Aguzzi A, Baumann F, Bremer J (2008) The prion\u2019s elusive reason for being. Annu Rev Neurosci 31:439\u2013477","journal-title":"Annu Rev Neurosci"},{"key":"3582_CR3","doi-asserted-by":"crossref","unstructured":"Altmeppen HC, Prox J, Krasemann S, Puig B, Kruszewski K, Dohler F, Bernreuther C, Hoxha A, Linsenmeier L, Sikorska B, Liberski PP, Bartsch U, Saftig P, Glatzel M (2015) The sheddase ADAM10 is a potent modulator of prion disease. Elife 4","DOI":"10.7554\/eLife.04260"},{"key":"3582_CR4","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1111\/febs.12196","volume":"280","author":"HC Altmeppen","year":"2013","unstructured":"Altmeppen HC, Prox J, Puig B, Dohler F, Falker C, Krasemann S, Glatzel M (2013) Roles of endoproteolytic \u03b1-cleavage and shedding of the prion protein in neurodegeneration. FEBS J 280:4338\u20134347","journal-title":"FEBS J"},{"key":"3582_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-1326-6-36","volume":"6","author":"HC Altmeppen","year":"2011","unstructured":"Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D, Jorissen E, Petrowitz B, Bartsch U, De Strooper B, Saftig P, Glatzel M (2011) Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener 6:36","journal-title":"Mol Neurodegener"},{"key":"3582_CR6","first-page":"15","volume":"1","author":"HC Altmeppen","year":"2012","unstructured":"Altmeppen HC, Puig B, Dohler F, Thurm DK, Falker C, Krasemann S, Glatzel M (2012) Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis 1:15\u201331","journal-title":"Am J Neurodegener Dis"},{"key":"3582_CR7","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1038\/s41467-021-23507-z","volume":"12","author":"L Amin","year":"2021","unstructured":"Amin L, Harris DA (2021) A\u03b2 receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun 12:3451","journal-title":"Nat Commun"},{"key":"3582_CR8","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1242\/jcs.183137","volume":"129","author":"L Amin","year":"2016","unstructured":"Amin L, Nguyen XTA, Rolle IG, D\u2019Este E, Giachin G, Tran TH, \u0160erbec V\u010c, Cojoc D, Legname G (2016) Characterization of prion protein function by focal neurite stimulation. J Cell Sci 129:3878\u20133891","journal-title":"J Cell Sci"},{"key":"3582_CR9","doi-asserted-by":"publisher","first-page":"661462","DOI":"10.3389\/fcell.2021.661462","volume":"9","author":"D Appel","year":"2021","unstructured":"Appel D, Hummel R, Weidemeier M, Endres K, G\u00f6lz C, Sch\u00e4fer MKE (2021) Pharmacologic inhibition of ADAM10 attenuates brain tissue loss, axonal injury and pro-inflammatory gene expression following traumatic brain injury in mice. Front Cell Dev Biol 9:661462","journal-title":"Front Cell Dev Biol"},{"key":"3582_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/1878-0261.12411","volume":"13","author":"CJ Atkinson","year":"2019","unstructured":"Atkinson CJ, Kawamata F, Liu C, Ham S, Gy\u0151rffy B, Munn AL, Wei MQ, M\u00f6ller A, Whitehall V, Wiegmans AP (2019) EGFR and Prion protein promote signaling via FOXO3a-KLF5 resulting in clinical resistance to platinum agents in colorectal cancer. Mol Oncol 13:725\u2013737","journal-title":"Mol Oncol"},{"key":"3582_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3389\/fimmu.2015.00450","volume":"6","author":"MK Bakkeb\u00f8","year":"2015","unstructured":"Bakkeb\u00f8 MK, Mouillet-Richard S, Espenes A, Goldmann W, Tatzelt J, Tranulis MA (2015) The Cellular Prion Protein: A Player in Immunological Quiescence. Front Immunol 6:450","journal-title":"Front Immunol"},{"key":"3582_CR12","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4161\/auto.7.8.15615","volume":"7","author":"G Barbieri","year":"2011","unstructured":"Barbieri G, Palumbo S, Gabrusiewicz K, Azzalin A, Marchesi N, Spedito A, Biggiogera M, Sbalchiero E, Mazzini G, Miracco C, Pirtoli L, Kaminska B, Comincini S (2011) Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells. Autophagy 7:840\u2013853","journal-title":"Autophagy"},{"key":"3582_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0092-8674(86)90662-8","volume":"46","author":"K Basler","year":"1986","unstructured":"Basler K, Oesch B, Scott M, Westaway D, W\u00e4lchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46:417\u2013428","journal-title":"Cell"},{"key":"3582_CR14","doi-asserted-by":"publisher","first-page":"e8221","DOI":"10.1371\/journal.pone.0008221","volume":"4","author":"C Bate","year":"2009","unstructured":"Bate C, Tayebi M, Diomede L, Salmona M, Williams A (2009) Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines. PLoS One 4:e8221","journal-title":"PLoS ONE"},{"key":"3582_CR15","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.neurobiolaging.2014.02.001","volume":"35","author":"M B\u00e9land","year":"2014","unstructured":"B\u00e9land M, B\u00e9dard M, Tremblay G, Lavigne P, Roucou X (2014) A\u03b2 induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates. Neurobiol Aging 35:1537\u20131548","journal-title":"Neurobiol Aging"},{"key":"3582_CR16","doi-asserted-by":"publisher","first-page":"13255","DOI":"10.1523\/JNEUROSCI.2236-12.2012","volume":"32","author":"M B\u00e9land","year":"2012","unstructured":"B\u00e9land M, Motard J, Barbarin A, Roucou X (2012) PrP(C) homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1. J Neurosci 32:13255\u201313263","journal-title":"J Neurosci"},{"key":"3582_CR17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1471-4159.2011.07613.x","volume":"120","author":"M B\u00e9land","year":"2012","unstructured":"B\u00e9land M, Roucou X (2012) The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions. J Neurochem 120:853\u2013868","journal-title":"J Neurochem"},{"key":"3582_CR18","doi-asserted-by":"publisher","first-page":"21945","DOI":"10.1074\/jbc.M116.738286","volume":"291","author":"FH Beraldo","year":"2016","unstructured":"Beraldo FH, Ostapchenko VG, Caetano FA, Guimaraes ALS, Ferretti GDS, Daude N, Bertram L, Nogueira KOPC, Silva JL, Westaway D, Cashman NR, Martins VR, Prado VF, Prado MAM (2016) Regulation of Amyloid \u03b2 Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex. J Biol Chem 291:21945\u201321955","journal-title":"J Biol Chem"},{"key":"3582_CR19","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1038\/s41388-021-01746-0","volume":"40","author":"J Bernardino-Sgherri","year":"2021","unstructured":"Bernardino-Sgherri J, Siberchicot C, Auvr\u00e9 F, Busso D, Brocas C, El Masri G, Lioutsko A, Ferri F, Radicella JP, Romeo P-H, Bravard A (2021) Tumor resistance to radiotherapy is triggered by an ATM\/TAK1-dependent-increased expression of the cellular prion protein. Oncogene 40:3460\u20133469","journal-title":"Oncogene"},{"key":"3582_CR20","doi-asserted-by":"publisher","first-page":"e1000837","DOI":"10.1371\/journal.ppat.1000837","volume":"6","author":"RA Bessen","year":"2010","unstructured":"Bessen RA, Shearin H, Martinka S, Boharski R, Lowe D, Wilham JM, Caughey B, Wiley JA (2010) Prion shedding from olfactory neurons into nasal secretions. PLoS Pathog 6:e1000837","journal-title":"PLoS Pathog"},{"key":"3582_CR21","doi-asserted-by":"publisher","first-page":"e1009748","DOI":"10.1371\/journal.ppat.1009748","volume":"17","author":"J Bian","year":"2021","unstructured":"Bian J, Kim S, Kane SJ, Crowell J, Sun JL, Christiansen J, Saijo E, Moreno JA, DiLisio J, Burnett E, Pritzkow S, Gorski D, Soto C, Kreeger TJ, Balachandran A, Mitchell G, Miller MW, Nonno R, Vik\u00f8ren T, V\u00e5ge J, Madslien K, Tran L, Vuong TT, Benestad SL, Telling GC (2021) Adaptive selection of a prion strain conformer corresponding to established North American CWD during propagation of novel emergent Norwegian strains in mice expressing elk or deer prion protein. PLoS Pathog 17:e1009748","journal-title":"PLoS Pathog"},{"key":"3582_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41419-020-2430-3","volume":"11","author":"Y Bignon","year":"2020","unstructured":"Bignon Y, Poindessous V, Lazareth H, Passet B, Vilotte J-L, Djouadi F, Mouillet-Richard S, Pallet N (2020) The cellular prion protein is a stress protein secreted by renal tubular cells and a urinary marker of kidney injury. Cell Death Dis 11:243","journal-title":"Cell Death Dis"},{"key":"3582_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM198501103120202","volume":"312","author":"JM Bockman","year":"1985","unstructured":"Bockman JM, Kingsbury DT, McKinley MP, Bendheim PE, Prusiner SB (1985) Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med 312:73\u201378","journal-title":"N Engl J Med"},{"key":"3582_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-020-02198-8","volume":"140","author":"BDC Boon","year":"2020","unstructured":"Boon BDC, Bulk M, Jonker AJ, Morrema THJ, van den Berg E, Popovic M, Walter J, Kumar S, van der Lee SJ, Holstege H, Zhu X, Van Nostrand WE, Natt\u00e9 R, van der Weerd L, Bouwman FH, van de Berg WDJ, Rozemuller AJM, Hoozemans JJM (2020) The coarse-grained plaque: a divergent A\u03b2 plaque-type in early-onset Alzheimer\u2019s disease. Acta Neuropathol 140:811\u2013830","journal-title":"Acta Neuropathol"},{"key":"3582_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/glycob\/3.4.319","volume":"3","author":"DR Borchelt","year":"1993","unstructured":"Borchelt DR, Rogers M, Stahl N, Telling G, Prusiner SB (1993) Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology 3:319\u2013329","journal-title":"Glycobiology"},{"key":"3582_CR26","doi-asserted-by":"publisher","first-page":"16858","DOI":"10.1074\/jbc.M117.789990","volume":"292","author":"E Bove-Fenderson","year":"2017","unstructured":"Bove-Fenderson E, Urano R, Straub JE, Harris DA (2017) Cellular prion protein targets amyloid-\u03b2 fibril ends via its C-terminal domain to prevent elongation. J Biol Chem 292:16858\u201316871","journal-title":"J Biol Chem"},{"key":"3582_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nn.2483","volume":"13","author":"J Bremer","year":"2010","unstructured":"Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, Steele AD, Toyka KV, Nave K-A, Weis J, Aguzzi A (2010) Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 13:310\u2013318","journal-title":"Nat Neurosci"},{"key":"3582_CR28","doi-asserted-by":"publisher","first-page":"1809065","DOI":"10.1080\/20013078.2020.1809065","volume":"9","author":"S Brenna","year":"2020","unstructured":"Brenna S, Altmeppen HC, Mohammadi B, Rissiek B, Schlink F, Ludewig P, Krisp C, Schl\u00fcter H, Failla AV, Schneider C, Glatzel M, Puig B, Magnus T (2020) Characterization of brain-derived extracellular vesicles reveals changes in cellular origin after stroke and enrichment of the prion protein with a potential role in cellular uptake. J Extracell Vesicles 9:1809065","journal-title":"J Extracell Vesicles"},{"key":"3582_CR29","doi-asserted-by":"publisher","first-page":"40313","DOI":"10.1038\/srep40313","volume":"7","author":"D Brethour","year":"2017","unstructured":"Brethour D, Mehrabian M, Williams D, Wang X, Ghodrati F, Ehsani S, Rubie EA, Woodgett JR, Sevalle J, Xi Z, Rogaeva E, Schmitt-Ulms G (2017) A ZIP6-ZIP10 heteromer controls NCAM1 phosphorylation and integration into focal adhesion complexes during epithelial-to-mesenchymal transition. Sci Rep 7:40313","journal-title":"Sci Rep"},{"key":"3582_CR30","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","volume":"73","author":"H B\u00fceler","year":"1993","unstructured":"B\u00fceler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339\u20131347","journal-title":"Cell"},{"key":"3582_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/emmm.201000082","volume":"2","author":"AM Calella","year":"2010","unstructured":"Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, Mansuy IM, Aguzzi A (2010) Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2:306\u2013314","journal-title":"EMBO Mol Med"},{"key":"3582_CR32","doi-asserted-by":"publisher","first-page":"104955","DOI":"10.1016\/j.nbd.2020.104955","volume":"142","author":"JA Callender","year":"2020","unstructured":"Callender JA, Sevillano AM, Soldau K, Kurt TD, Schumann T, Pizzo DP, Altmeppen H, Glatzel M, Esko JD, Sigurdson CJ (2020) Prion protein post-translational modifications modulate heparan sulfate binding and limit aggregate size in prion disease. Neurobiol Dis 142:104955","journal-title":"Neurobiol Dis"},{"key":"3582_CR33","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1038\/s41374-019-0282-1","volume":"99","author":"MV Camacho","year":"2019","unstructured":"Camacho MV, Telling G, Kong Q, Gambetti P, Notari S (2019) Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification. Lab Invest 99:1741\u20131748","journal-title":"Lab Invest"},{"key":"3582_CR34","doi-asserted-by":"publisher","first-page":"6654","DOI":"10.1038\/s41598-020-63472-z","volume":"10","author":"JA Carroll","year":"2020","unstructured":"Carroll JA, Groveman BR, Williams K, Moore R, Race B, Haigh CL (2020) Prion protein N1 cleavage peptides stimulate microglial interaction with surrounding cells. Sci Rep 10:6654","journal-title":"Sci Rep"},{"key":"3582_CR35","doi-asserted-by":"publisher","first-page":"11971","DOI":"10.1038\/srep11971","volume":"5","author":"P Carulla","year":"2015","unstructured":"Carulla P, Llorens F, Matamoros-Angles A, Aguilar-Calvo P, Espinosa JC, Gav\u00edn R, Ferrer I, Legname G, Torres JM, del R\u00edo JA (2015) Involvement of PrP(C) in kainate-induced excitotoxicity in several mouse strains. Sci Rep 5:11971","journal-title":"Sci Rep"},{"key":"3582_CR36","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1074\/jbc.RA118.006367","volume":"294","author":"AR Castle","year":"2019","unstructured":"Castle AR, Daude N, Gilch S, Westaway D (2019) Application of high-throughput, capillary-based Western analysis to modulated cleavage of the cellular prion protein. J Biol Chem 294:2642\u20132650","journal-title":"J Biol Chem"},{"key":"3582_CR37","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1128\/jvi.64.3.1093-1101.1990","volume":"64","author":"B Caughey","year":"1990","unstructured":"Caughey B, Neary K, Buller R, Ernst D, Perry LL, Chesebro B, Race RE (1990) Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J Virol 64:1093\u20131101","journal-title":"J Virol"},{"key":"3582_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1128\/jvi.63.1.175-181.1989","volume":"63","author":"B Caughey","year":"1989","unstructured":"Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B (1989) Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 63:175\u2013181","journal-title":"J Virol"},{"key":"3582_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1044-7431(02)00014-3","volume":"22","author":"S Chen","year":"2003","unstructured":"Chen S, Mang\u00e9 A, Dong L, Lehmann S, Schachner M (2003) Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci 22:227\u2013233","journal-title":"Mol Cell Neurosci"},{"key":"3582_CR40","doi-asserted-by":"publisher","first-page":"26377","DOI":"10.1074\/jbc.M110.145516","volume":"285","author":"S Chen","year":"2010","unstructured":"Chen S, Yadav SP, Surewicz WK (2010) Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. J Biol Chem 285:26377\u201326383","journal-title":"J Biol Chem"},{"key":"3582_CR41","doi-asserted-by":"publisher","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","volume":"270","author":"SG Chen","year":"1995","unstructured":"Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270:19173\u201319180","journal-title":"J Biol Chem"},{"key":"3582_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/jnc.14044","volume":"142","author":"CJ Cheng","year":"2017","unstructured":"Cheng CJ, Kolds\u00f8 H, Van der Kamp MW, Schi\u00f8tt B, Daggett V (2017) Simulations of membrane-bound diglycosylated human prion protein reveal potential protective mechanisms against misfolding. J Neurochem 142:171\u2013182","journal-title":"J Neurochem"},{"key":"3582_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12935-020-01727-5","volume":"21","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Lin L, Li X, Lu A, Hou C, Wu Q, Hu X, Zhou Z, Chen Z, Tang F (2021) ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc. Cancer Cell Int 21:32","journal-title":"Cancer Cell Int"},{"key":"3582_CR44","doi-asserted-by":"publisher","first-page":"e1000800","DOI":"10.1371\/journal.ppat.1000800","volume":"6","author":"B Chesebro","year":"2010","unstructured":"Chesebro B, Race B, Meade-White K, Lacasse R, Race R, Klingeborn M, Striebel J, Dorward D, McGovern G, Jeffrey M (2010) Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 6:e1000800","journal-title":"PLoS Pathog"},{"key":"3582_CR45","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.1110837","volume":"308","author":"B Chesebro","year":"2005","unstructured":"Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435\u20131439","journal-title":"Science"},{"key":"3582_CR46","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1093\/emboj\/cdf324","volume":"21","author":"LB Chiarini","year":"2002","unstructured":"Chiarini LB, Freitas ARO, Zanata SM, Brentani RR, Martins VR, Linden R (2002) Cellular prion protein transduces neuroprotective signals. EMBO J 21:3317\u20133326","journal-title":"EMBO J"},{"key":"3582_CR47","doi-asserted-by":"publisher","first-page":"13851","DOI":"10.1073\/pnas.1610716113","volume":"113","author":"J-K Choi","year":"2016","unstructured":"Choi J-K, Cali I, Surewicz K, Kong Q, Gambetti P, Surewicz WK (2016) Amyloid fibrils from the N-terminal prion protein fragment are infectious. Proc Natl Acad Sci U S A 113:13851\u201313856","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2202-11-130","volume":"11","author":"E Chung","year":"2010","unstructured":"Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, Strittmatter SM, Wisniewski T (2010) Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer\u2019s disease model mouse. BMC Neurosci 11:130","journal-title":"BMC Neurosci"},{"key":"3582_CR49","doi-asserted-by":"publisher","first-page":"a006833","DOI":"10.1101\/cshperspect.a006833","volume":"3","author":"DW Colby","year":"2011","unstructured":"Colby DW, Prusiner SB (2011) Prions. Cold Spring Harb Perspect Biol 3:a006833","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3582_CR50","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s00018-018-2790-3","volume":"75","author":"SJ Collins","year":"2018","unstructured":"Collins SJ, Tumpach C, Groveman BR, Drew SC, Haigh CL (2018) Prion protein cleavage fragments regulate adult neural stem cell quiescence through redox modulation of mitochondrial fission and SOD2 expression. Cell Mol Life Sci 75:3231\u20133249","journal-title":"Cell Mol Life Sci"},{"key":"3582_CR51","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.tips.2015.08.004","volume":"36","author":"F Colombo","year":"2015","unstructured":"Colombo F, Meldolesi J (2015) L1-CAM and N-CAM: from adhesion proteins to pharmacological targets. Trends Pharmacol Sci 36:769\u2013781","journal-title":"Trends Pharmacol Sci"},{"key":"3582_CR52","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","volume":"139","author":"GT Corbett","year":"2020","unstructured":"Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, Liao M, Asfaw A, Hall TC, Ding L, DeSousa A, Frosch MP, Collinge J, Harris DA, Perkinton MS, Spires-Jones TL, Young-Pearse TL, Billinton A, Walsh DM (2020) PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol 139:503\u2013526","journal-title":"Acta Neuropathol"},{"key":"3582_CR53","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.1007\/s12035-018-0944-9","volume":"55","author":"E Corda","year":"2018","unstructured":"Corda E, Du X, Shim SY, Klein AN, Siltberg-Liberles J, Gilch S (2018) Interaction of peptide aptamers with prion protein central domain promotes \u03b1-cleavage of PrPC. Mol Neurobiol 55:7758\u20137774","journal-title":"Mol Neurobiol"},{"key":"3582_CR54","doi-asserted-by":"publisher","first-page":"38638","DOI":"10.18632\/oncotarget.9575","volume":"7","author":"A Corsaro","year":"2016","unstructured":"Corsaro A, Bajetto A, Thellung S, Begani G, Villa V, Nizzari M, Pattarozzi A, Solari A, Gatti M, Pagano A, W\u00fcrth R, Daga A, Barbieri F, Florio T (2016) Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells. Oncotarget 7:38638\u201338657","journal-title":"Oncotarget"},{"key":"3582_CR55","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.2174\/138161209788682442","volume":"15","author":"HC Crawford","year":"2009","unstructured":"Crawford HC, Dempsey PJ, Brown G, Adam L, Moss ML (2009) ADAM10 as a therapeutic target for cancer and inflammation. Curr Pharm Des 15:2288\u20132299","journal-title":"Curr Pharm Des"},{"key":"3582_CR56","doi-asserted-by":"crossref","first-page":"e12114","DOI":"10.1002\/jev2.12114","volume":"10","author":"G D\u2019Arrigo","year":"2021","unstructured":"D\u2019Arrigo G, Gabrielli M, Scaroni F, Swuec P, Amin L, Pegoraro A, Adinolfi E, Di Virgilio F, Cojoc D, Legname G, Verderio C (2021) Astrocytes-derived extracellular vesicles in motion at the neuron surface: Involvement of the prion protein. J Extracell Vesicles 10:e12114","journal-title":"J Extracell Vesicles"},{"key":"3582_CR57","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/jnc.15040","volume":"155","author":"E De Cecco","year":"2020","unstructured":"De Cecco E, Celauro L, Vanni S, Grandolfo M, Bistaffa E, Moda F, Aguzzi A, Legname G (2020) The uptake of tau amyloid fibrils is facilitated by the cellular prion protein and hampers prion propagation in cultured cells. J Neurochem 155:577\u2013591","journal-title":"J Neurochem"},{"key":"3582_CR58","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10585-016-9788-8","volume":"33","author":"TCS de Lacerda","year":"2016","unstructured":"de Lacerda TCS, Costa-Silva B, Giudice FS, Dias MVS, de Oliveira GP, Teixeira BL, Dos Santos TG, Martins VR (2016) Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells. Clin Exp Metastasis 33:441\u2013451","journal-title":"Clin Exp Metastasis"},{"key":"3582_CR59","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S0896-6273(00)80424-9","volume":"19","author":"SJ DeArmond","year":"1997","unstructured":"DeArmond SJ, S\u00e1nchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, Prusiner SB (1997) Selective neuronal targeting in prion disease. Neuron 19:1337\u20131348","journal-title":"Neuron"},{"key":"3582_CR60","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1471-4159.2009.05892.x","volume":"109","author":"ML DeMarco","year":"2009","unstructured":"DeMarco ML, Daggett V (2009) Characterization of cell-surface prion protein relative to its recombinant analogue: insights from molecular dynamics simulations of diglycosylated, membrane-bound human prion protein. J Neurochem 109:60\u201373","journal-title":"J Neurochem"},{"key":"3582_CR61","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.bbamcr.2017.07.011","volume":"1864","author":"PJ Dempsey","year":"2017","unstructured":"Dempsey PJ (2017) Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis. Biochim Biophys Acta Mol Cell Res 1864:2228\u20132239","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3582_CR62","doi-asserted-by":"publisher","first-page":"e0237410","DOI":"10.1371\/journal.pone.0237410","volume":"15","author":"ND Denkers","year":"2020","unstructured":"Denkers ND, Hoover CE, Davenport KA, Henderson DM, McNulty EE, Nalls AV, Mathiason CK, Hoover EA (2020) Very low oral exposure to prions of brain or saliva origin can transmit chronic wasting disease. PLoS One 15:e0237410","journal-title":"PLoS ONE"},{"key":"3582_CR63","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/14737175.2021.1965881","volume":"21","author":"E Dexter","year":"2021","unstructured":"Dexter E, Kong Q (2021a) Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review. Expert Rev Neurother 21:969\u2013982","journal-title":"Expert Rev Neurother"},{"key":"3582_CR64","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/14737175.2021.1965882","volume":"21","author":"E Dexter","year":"2021","unstructured":"Dexter E, Kong Q (2021b) Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development. Expert Rev Neurother 21:983\u2013991","journal-title":"Expert Rev Neurother"},{"key":"3582_CR65","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00401-021-02296-1","volume":"141","author":"D Diaz-Lucena","year":"2021","unstructured":"Diaz-Lucena D, Kruse N, Th\u00fcne K, Schmitz M, Villar-Piqu\u00e9 A, da Cunha JEG, Hermann P, L\u00f3pez-P\u00e9rez \u00d3, Andr\u00e9s-Benito P, Ladogana A, Calero M, Vidal E, Riggert J, Pineau H, Sim V, Zetterberg H, Blennow K, Del R\u00edo JA, Mar\u00edn-Moreno A, Espinosa JC, Torres JM, S\u00e1nchez-Valle R, Mollenhauer B, Ferrer I, Zerr I, Llorens F (2021) TREM2 expression in the brain and biological fluids in prion diseases. Acta Neuropathol 141:841\u2013859","journal-title":"Acta Neuropathol"},{"key":"3582_CR66","doi-asserted-by":"publisher","first-page":"e2024","DOI":"10.1038\/cddis.2015.365","volume":"6","author":"TR Doeppner","year":"2015","unstructured":"Doeppner TR, Kaltwasser B, Schlechter J, Jaschke J, Kilic E, B\u00e4hr M, Hermann DM, Weise J (2015) Cellular prion protein promotes post-ischemic neuronal survival, angioneurogenesis and enhances neural progenitor cell homing via proteasome inhibition. Cell Death Dis 6:e2024","journal-title":"Cell Death Dis"},{"key":"3582_CR67","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/brain\/awt375","volume":"137","author":"F Dohler","year":"2014","unstructured":"Dohler F, Sepulveda-Falla D, Krasemann S, Altmeppen H, Schl\u00fcter H, Hildebrand D, Zerr I, Matschke J, Glatzel M (2014) High molecular mass assemblies of amyloid-\u03b2 oligomers bind prion protein in patients with Alzheimer\u2019s disease. Brain 137:873\u2013886","journal-title":"Brain"},{"key":"3582_CR68","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1158\/0008-5472.CAN-12-3759","volume":"73","author":"L Du","year":"2013","unstructured":"Du L, Rao G, Wang H, Li B, Tian W, Cui J, He L, Laffin B, Tian X, Hao C, Liu H, Sun X, Zhu Y, Tang DG, Mehrpour M, Lu Y, Chen Q (2013) CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer. Cancer Res 73:2682\u20132694","journal-title":"Cancer Res"},{"key":"3582_CR69","doi-asserted-by":"publisher","first-page":"9295","DOI":"10.1073\/pnas.151242598","volume":"98","author":"M Enari","year":"2001","unstructured":"Enari M, Flechsig E, Weissmann C (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A 98:9295\u20139299","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR70","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000001017","volume":"83","author":"K Endres","year":"2014","unstructured":"Endres K, Fahrenholz F, Lotz J, Hiemke C, Teipel S, Lieb K, T\u00fcscher O, Fellgiebel A (2014) Increased CSF APPs-\u03b1 levels in patients with Alzheimer disease treated with acitretin. Neurology 83:1930\u20131935","journal-title":"Neurology"},{"key":"3582_CR71","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.nbd.2009.07.015","volume":"36","author":"K Endres","year":"2009","unstructured":"Endres K, Mitteregger G, Kojro E, Kretzschmar H, Fahrenholz F (2009) Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol Dis 36:233\u2013241","journal-title":"Neurobiol Dis"},{"key":"3582_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jnc.13514","volume":"137","author":"C Falker","year":"2016","unstructured":"Falker C, Hartmann A, Guett I, Dohler F, Altmeppen H, Betzel C, Schubert R, Thurm D, Wegwitz F, Joshi P, Verderio C, Krasemann S, Glatzel M (2016) Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity. J Neurochem 137:88\u2013100","journal-title":"J Neurochem"},{"key":"3582_CR73","doi-asserted-by":"publisher","first-page":"11247","DOI":"10.1074\/jbc.M407006200","volume":"280","author":"C F\u00e9raudet","year":"2005","unstructured":"F\u00e9raudet C, Morel N, Simon S, Volland H, Frobert Y, Cr\u00e9minon C, Vilette D, Lehmann S, Grassi J (2005) Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem 280:11247\u201311258","journal-title":"J Biol Chem"},{"key":"3582_CR74","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4648","volume":"20","author":"DG Ferreira","year":"2017","unstructured":"Ferreira DG, Temido-Ferreira M, Vicente Miranda H, Batalha VL, Coelho JE, Szeg\u00f6 \u00c9M, Marques-Morgado I, Vaz SH, Rhee JS, Schmitz M, Zerr I, Lopes LV, Outeiro TF (2017) \u03b1-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nat Neurosci 20:1569\u20131579","journal-title":"Nat Neurosci"},{"key":"3582_CR75","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s004010000271","volume":"101","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, Blanco R, Carmona M, Puig B, Ribera R, Rey MJ, Ribalta T (2001) Prion protein expression in senile plaques in Alzheimer\u2019s disease. Acta Neuropathol 101:49\u201356","journal-title":"Acta Neuropathol"},{"key":"3582_CR76","doi-asserted-by":"publisher","first-page":"9683","DOI":"10.1073\/pnas.0308413101","volume":"101","author":"B Fevrier","year":"2004","unstructured":"Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, Laude H, Raposo G (2004) Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 101:9683\u20139688","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR77","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/j.1460-2075.1996.tb00467.x","volume":"15","author":"M Fischer","year":"1996","unstructured":"Fischer M, R\u00fclicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15:1255\u20131264","journal-title":"EMBO J"},{"key":"3582_CR78","doi-asserted-by":"publisher","first-page":"7857","DOI":"10.1074\/jbc.M112.423954","volume":"288","author":"BR Fluharty","year":"2013","unstructured":"Fluharty BR, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C, La Vitola P, Messa M, Colombo L, Forloni G, Borsello T, Gobbi M, Harris DA (2013) An N-terminal fragment of the prion protein binds to amyloid-\u03b2 oligomers and inhibits their neurotoxicity in vivo. J Biol Chem 288:7857\u20137866","journal-title":"J Biol Chem"},{"key":"3582_CR79","doi-asserted-by":"publisher","first-page":"28625","DOI":"10.1073\/pnas.2009238117","volume":"117","author":"AR Foley","year":"2020","unstructured":"Foley AR, Roseman GP, Chan K, Smart A, Finn TS, Yang K, Lokey RS, Millhauser GL, Raskatov JA (2020) Evidence for aggregation-independent, PrPC-mediated A\u03b2 cellular internalization. Proc Natl Acad Sci U S A 117:28625\u201328631","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR80","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1160\/TH14-10-0899","volume":"114","author":"M Folkesson","year":"2015","unstructured":"Folkesson M, Li C, Frebelius S, Swedenborg J, W\u00e5gs\u00e4ter D, Williams KJ, Eriksson P, Roy J, Liu M-L (2015) Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms. Thromb Haemost 114:1165\u20131174","journal-title":"Thromb Haemost"},{"key":"3582_CR81","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/ncomms1341","volume":"2","author":"DB Freir","year":"2011","unstructured":"Freir DB, Nicoll AJ, Klyubin I, Panico S, Mc Donald JM, Risse E, Asante EA, Farrow MA, Sessions RB, Saibil HR, Clarke AR, Rowan MJ, Walsh DM, Collinge J (2011) Interaction between prion protein and toxic amyloid \u03b2 assemblies can be therapeutically targeted at multiple sites. Nat Commun 2:336","journal-title":"Nat Commun"},{"key":"3582_CR82","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1093\/emboj\/20.21.5863","volume":"20","author":"S Gauczynski","year":"2001","unstructured":"Gauczynski S, Peyrin JM, Ha\u00efk S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasm\u00e9zas CI, Weiss S (2001) The 37-kDa\/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20:5863\u20135875","journal-title":"EMBO J"},{"key":"3582_CR83","doi-asserted-by":"publisher","first-page":"1940674","DOI":"10.1080\/2162402X.2021.1940674","volume":"10","author":"A Ghazi","year":"2021","unstructured":"Ghazi A, Le Corre D, Pilati C, Taieb J, Aparicio T, Didelot A, Dedhar S, Mulot C, Le Malicot K, Djouadi F, de Reynies A, Launay J-M, Laurent-Puig P, Mouillet-Richard S (2021) Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype. Oncoimmunology 10:1940674","journal-title":"Oncoimmunology"},{"key":"3582_CR84","doi-asserted-by":"publisher","first-page":"18524","DOI":"10.1074\/jbc.M210723200","volume":"278","author":"S Gilch","year":"2003","unstructured":"Gilch S, Wopfner F, Renner-M\u00fcller I, Kremmer E, Bauer C, Wolf E, Brem G, Groschup MH, Sch\u00e4tzl HM (2003) Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J Biol Chem 278:18524\u201318531","journal-title":"J Biol Chem"},{"key":"3582_CR85","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","volume":"30","author":"DA Gimbel","year":"2010","unstructured":"Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laur\u00e9n J, Gimbel ZA, Strittmatter SM (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30:6367\u20136374","journal-title":"J Neurosci"},{"key":"3582_CR86","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00401-019-02053-5","volume":"138","author":"LA Gomes","year":"2019","unstructured":"Gomes LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, Ospitalieri S, Koper MJ, Largo-Barrientos P, Uytterhoeven V, Reichwald J, Rabe S, Vandenberghe R, von Arnim CAF, Tousseyn T, Feederle R, Giudici C, Willem M, Staufenbiel M, Thal DR (2019) A\u03b2-induced acceleration of Alzheimer-related \u03c4-pathology spreading and its association with prion protein. Acta Neuropathol 138:913\u2013941","journal-title":"Acta Neuropathol"},{"key":"3582_CR87","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajpath.2013.08.029","volume":"184","author":"SL Gonias","year":"2014","unstructured":"Gonias SL, Campana WM (2014) LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system. Am J Pathol 184:18\u201327","journal-title":"Am J Pathol"},{"key":"3582_CR88","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/156652412799218912","volume":"12","author":"M-V Guillot-Sestier","year":"2012","unstructured":"Guillot-Sestier M-V, Checler F (2012) Cellular prion and its catabolites in the brain: production and function. Curr Mol Med 12:304\u2013315","journal-title":"Curr Mol Med"},{"key":"3582_CR89","doi-asserted-by":"publisher","first-page":"35973","DOI":"10.1074\/jbc.M109.051086","volume":"284","author":"M-V Guillot-Sestier","year":"2009","unstructured":"Guillot-Sestier M-V, Sunyach C, Druon C, Scarzello S, Checler F (2009) The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem 284:35973\u201335986","journal-title":"J Biol Chem"},{"key":"3582_CR90","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1074\/jbc.M111.323626","volume":"287","author":"M-V Guillot-Sestier","year":"2012","unstructured":"Guillot-Sestier M-V, Sunyach C, Ferreira ST, Marzolo M-P, Bauer C, Thevenet A, Checler F (2012) \u03b1-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid \u03b2 (A\u03b2)-associated cell death. J Biol Chem 287:5021\u20135032","journal-title":"J Biol Chem"},{"key":"3582_CR91","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/glia.22963","volume":"64","author":"K Guitart","year":"2016","unstructured":"Guitart K, Loers G, Buck F, Bork U, Schachner M, Kleene R (2016) Improvement of neuronal cell survival by astrocyte-derived exosomes under hypoxic and ischemic conditions depends on prion protein. Glia 64:896\u2013910","journal-title":"Glia"},{"key":"3582_CR92","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1074\/jbc.M115.684258","volume":"291","author":"BB Guo","year":"2016","unstructured":"Guo BB, Bellingham SA, Hill AF (2016) Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions. J Biol Chem 291:5128\u20135137","journal-title":"J Biol Chem"},{"key":"3582_CR93","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1074\/jbc.M114.605253","volume":"290","author":"BB Guo","year":"2015","unstructured":"Guo BB, Bellingham SA, Hill AF (2015) The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes. J Biol Chem 290:3455\u20133467","journal-title":"J Biol Chem"},{"key":"3582_CR94","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1086\/605022","volume":"200","author":"DJ Haddon","year":"2009","unstructured":"Haddon DJ, Hughes MR, Antignano F, Westaway D, Cashman NR, McNagny KM (2009) Prion protein expression and release by mast cells after activation. J Infect Dis 200:827\u2013831","journal-title":"J Infect Dis"},{"key":"3582_CR95","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1242\/jcs.043604","volume":"122","author":"CL Haigh","year":"2009","unstructured":"Haigh CL, Drew SC, Boland MP, Masters CL, Barnham KJ, Lawson VA, Collins SJ (2009a) Dominant roles of the polybasic proline motif and copper in the PrP23-89-mediated stress protection response. J Cell Sci 122:1518\u20131528","journal-title":"J Cell Sci"},{"key":"3582_CR96","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/cr.2009.86","volume":"19","author":"CL Haigh","year":"2009","unstructured":"Haigh CL, Lewis VA, Vella LJ, Masters CL, Hill AF, Lawson VA, Collins SJ (2009b) PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site. Cell Res 19:1062\u20131078","journal-title":"Cell Res"},{"key":"3582_CR97","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00018-014-1777-y","volume":"72","author":"CL Haigh","year":"2015","unstructured":"Haigh CL, McGlade AR, Collins SJ (2015) MEK1 transduces the prion protein N2 fragment antioxidant effects. Cell Mol Life Sci 72:1613\u20131629","journal-title":"Cell Mol Life Sci"},{"key":"3582_CR98","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13041-015-0107-0","volume":"8","author":"A Hamilton","year":"2015","unstructured":"Hamilton A, Zamponi GW, Ferguson SSG (2015) Glutamate receptors function as scaffolds for the regulation of \u03b2-amyloid and cellular prion protein signaling complexes. Mol Brain 8:18","journal-title":"Mol Brain"},{"key":"3582_CR99","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.7150\/ijms.42603","volume":"17","author":"Y-S Han","year":"2020","unstructured":"Han Y-S, Yoon YM, Go G, Lee JH, Lee SH (2020) Melatonin protects human renal proximal tubule epithelial cells against high glucose-mediated fibrosis via the cellular prion protein-TGF-\u03b2-smad signaling axis. Int J Med Sci 17:1235\u20131245","journal-title":"Int J Med Sci"},{"key":"3582_CR100","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1021\/bi00055a003","volume":"32","author":"DA Harris","year":"1993","unstructured":"Harris DA, Huber MT, van Dijken P, Shyng SL, Chait BT, Wang R (1993) Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry 32:1009\u20131016","journal-title":"Biochemistry"},{"key":"3582_CR101","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1600-0854.2008.00750.x","volume":"9","author":"A Heiseke","year":"2008","unstructured":"Heiseke A, Sch\u00f6bel S, Lichtenthaler SF, Vorberg I, Groschup MH, Kretzschmar H, Sch\u00e4tzl HM, Nunziante M (2008) The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding. Traffic 9:1116\u20131129","journal-title":"Traffic"},{"key":"3582_CR102","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.neuron.2018.08.010","volume":"99","author":"FF Heisler","year":"2018","unstructured":"Heisler FF, Pechmann Y, Wieser I, Altmeppen HC, Veenendaal L, Muhia M, Schweizer M, Glatzel M, Krasemann S, Kneussel M (2018) Muskelin coordinates PrPC lysosome versus exosome targeting and impacts prion disease progression. Neuron 99:1155-1169.e9","journal-title":"Neuron"},{"key":"3582_CR103","doi-asserted-by":"crossref","unstructured":"Henzi A, Senatore A, Lakkaraju AKK, Scheckel C, M\u00fchle J, Reimann R, Sorce S, Schertler G, Toyka KV, Aguzzi A (2020)\u00a0Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice. PLoS One 15:e0242137","DOI":"10.1371\/journal.pone.0242137"},{"key":"3582_CR104","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1126\/science.1063093","volume":"294","author":"FL Heppner","year":"2001","unstructured":"Heppner FL, Musahl C, Arrighi I, Klein MA, R\u00fclicke T, Oesch B, Zinkernagel RM, Kalinke U, Aguzzi A (2001) Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294:178\u2013182","journal-title":"Science"},{"key":"3582_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.06.001","volume":"150","author":"TZ Hirsch","year":"2017","unstructured":"Hirsch TZ, Martin-Lanner\u00e9e S, Mouillet-Richard S (2017) Functions of the prion protein. Prog Mol Biol Transl Sci 150:1\u201334","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3582_CR106","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.celrep.2018.04.040","volume":"23","author":"N-W Hu","year":"2018","unstructured":"Hu N-W, Corbett GT, Moore S, Klyubin I, O\u2019Malley TT, Walsh DM, Livesey FJ, Rowan MJ (2018) Extracellular forms of A\u03b2 and tau from iPSC models of Alzheimer\u2019s disease disrupt synaptic plasticity. Cell Rep 23:1932\u20131938","journal-title":"Cell Rep"},{"key":"3582_CR107","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1038\/ncomms4374","volume":"5","author":"N-W Hu","year":"2014","unstructured":"Hu N-W, Nicoll AJ, Zhang D, Mably AJ, O\u2019Malley T, Purro SA, Terry C, Collinge J, Walsh DM, Rowan MJ (2014) mGlu5 receptors and cellular prion protein mediate amyloid-\u03b2-facilitated synaptic long-term depression in vivo. Nat Commun 5:3374","journal-title":"Nat Commun"},{"key":"3582_CR108","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13041-021-00828-0","volume":"14","author":"S Huang","year":"2021","unstructured":"Huang S, Black SA, Huang J, Stys PK, Zamponi GW (2021) Mutation of copper binding sites on cellular prion protein abolishes its inhibitory action on NMDA receptors in mouse hippocampal neurons. Mol Brain 14:117","journal-title":"Mol Brain"},{"key":"3582_CR109","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1093\/emboj\/20.21.5876","volume":"20","author":"C Hundt","year":"2001","unstructured":"Hundt C, Peyrin JM, Ha\u00efk S, Gauczynski S, Leucht C, Rieger R, Riley ML, Deslys JP, Dormont D, Lasm\u00e9zas CI, Weiss S (2001) Identification of interaction domains of the prion protein with its 37-kDa\/67-kDa laminin receptor. EMBO J 20:5876\u20135886","journal-title":"EMBO J"},{"key":"3582_CR110","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00401-009-0609-x","volume":"119","author":"C Jansen","year":"2010","unstructured":"Jansen C, Parchi P, Capellari S, Vermeij AJ, Corrado P, Baas F, Strammiello R, van Gool WA, van Swieten JC, Rozemuller AJM (2010) Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol 119:189\u2013197","journal-title":"Acta Neuropathol"},{"key":"3582_CR111","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1074\/jbc.RA118.005364","volume":"294","author":"HH Jarosz-Griffiths","year":"2019","unstructured":"Jarosz-Griffiths HH, Corbett NJ, Rowland HA, Fisher K, Jones AC, Baron J, Howell GJ, Cowley SA, Chintawar S, Cader MZ, Kellett KAB, Hooper NM (2019) Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-\u03b2 oligomers. J Biol Chem 294:7085\u20137097","journal-title":"J Biol Chem"},{"key":"3582_CR112","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1523\/JNEUROSCI.5221-09.2010","volume":"30","author":"E Jorissen","year":"2010","unstructured":"Jorissen E, Prox J, Bernreuther C, Weber S, Schwanbeck R, Serneels L, Snellinx A, Craessaerts K, Thathiah A, Tesseur I, Bartsch U, Weskamp G, Blobel CP, Glatzel M, De Strooper B, Saftig P (2010) The disintegrin\/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neurosci 30:4833\u20134844","journal-title":"J Neurosci"},{"key":"3582_CR113","doi-asserted-by":"publisher","first-page":"e51305","DOI":"10.1371\/journal.pone.0051305","volume":"7","author":"DM Kaiser","year":"2012","unstructured":"Kaiser DM, Acharya M, Leighton PLA, Wang H, Daude N, Wohlgemuth S, Shi B, Allison WT (2012) Amyloid beta precursor protein and prion protein have a conserved interaction affecting cell adhesion and CNS development. PLoS One 7:e51305","journal-title":"PLoS ONE"},{"key":"3582_CR114","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/j.1471-4159.2005.03469.x","volume":"95","author":"J Kanaani","year":"2005","unstructured":"Kanaani J, Prusiner SB, Diacovo J, Baekkeskov S, Legname G (2005) Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J Neurochem 95:1373\u20131386","journal-title":"J Neurochem"},{"key":"3582_CR115","doi-asserted-by":"publisher","first-page":"10420","DOI":"10.1074\/jbc.RA120.012796","volume":"295","author":"H-E Kang","year":"2020","unstructured":"Kang H-E, Bian J, Kane SJ, Kim S, Selwyn V, Crowell J, Bartz JC, Telling GC (2020) Incomplete glycosylation during prion infection unmasks a prion protein epitope that facilitates prion detection and strain discrimination. J Biol Chem 295:10420\u201310433","journal-title":"J Biol Chem"},{"key":"3582_CR116","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1083\/jcb.200711002","volume":"181","author":"H Khosravani","year":"2008","unstructured":"Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, Zamponi GW (2008) Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 181:551\u2013565","journal-title":"J Cell Biol"},{"key":"3582_CR117","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1523\/JNEUROSCI.3526-13.2014","volume":"34","author":"I Klyubin","year":"2014","unstructured":"Klyubin I, Nicoll AJ, Khalili-Shirazi A, Farmer M, Canning S, Mably A, Linehan J, Brown A, Wakeling M, Brandner S, Walsh DM, Rowan MJ, Collinge J (2014) Peripheral administration of a humanized anti-PrP antibody blocks Alzheimer\u2019s disease A\u03b2 synaptotoxicity. J Neurosci 34:6140\u20136145","journal-title":"J Neurosci"},{"key":"3582_CR118","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/biom4020510","volume":"4","author":"A Kojima","year":"2014","unstructured":"Kojima A, Konishi M, Akizawa T (2014) Prion fragment peptides are digested with membrane type matrix metalloproteinases and acquire enzyme resistance through Cu2+-binding. Biomolecules 4:510\u2013526","journal-title":"Biomolecules"},{"key":"3582_CR119","doi-asserted-by":"publisher","first-page":"100499","DOI":"10.1016\/j.jbc.2021.100499","volume":"296","author":"AS K\u00f6nig","year":"2021","unstructured":"K\u00f6nig AS, R\u00f6sener NS, Gremer L, Tusche M, Flender D, Reinartz E, Hoyer W, Neudecker P, Willbold D, Heise H (2021) Structural details of amyloid \u03b2 oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy. J Biol Chem 296:100499","journal-title":"J Biol Chem"},{"key":"3582_CR120","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature19312","volume":"536","author":"A K\u00fcffer","year":"2016","unstructured":"K\u00fcffer A, Lakkaraju AKK, Mogha A, Petersen SC, Airich K, Doucerain C, Marpakwar R, Bakirci P, Senatore A, Monnard A, Schiavi C, Nuvolone M, Grosshans B, Hornemann S, Bassilana F, Monk KR, Aguzzi A (2016) The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6. Nature 536:464\u2013468","journal-title":"Nature"},{"key":"3582_CR121","doi-asserted-by":"publisher","first-page":"e12748","DOI":"10.7554\/eLife.12748","volume":"5","author":"P-H Kuhn","year":"2016","unstructured":"Kuhn P-H, Colombo AV, Schusser B, Dreymueller D, Wetzel S, Schepers U, Herber J, Ludwig A, Kremmer E, Montag D, M\u00fcller U, Schweizer M, Saftig P, Br\u00e4se S, Lichtenthaler SF (2016) Systematic substrate identification indicates a central role for the metalloprotease ADAM10 in axon targeting and synapse function. Elife 5:e12748","journal-title":"Elife"},{"key":"3582_CR122","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1016\/j.febslet.2005.10.013","volume":"579","author":"I Laffont-Proust","year":"2005","unstructured":"Laffont-Proust I, Faucheux BA, H\u00e4ssig R, Sazdovitch V, Simon S, Grassi J, Hauw J-J, Moya KL, Ha\u00efk S (2005) The N-terminal cleavage of cellular prion protein in the human brain. FEBS Lett 579:6333\u20136337","journal-title":"FEBS Lett"},{"key":"3582_CR123","doi-asserted-by":"publisher","first-page":"16857","DOI":"10.1523\/JNEUROSCI.1858-12.2012","volume":"32","author":"M Larson","year":"2012","unstructured":"Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, Aguzzi A, Lesn\u00e9 SE (2012) The complex PrP(c)-Fyn couples human oligomeric A\u03b2 with pathological tau changes in Alzheimer\u2019s disease. J Neurosci 32:16857\u201316871a","journal-title":"J Neurosci"},{"key":"3582_CR124","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15252\/emmm.201404588","volume":"7","author":"A Lau","year":"2015","unstructured":"Lau A, McDonald A, Daude N, Mays CE, Walter ED, Aglietti R, Mercer RCC, Wohlgemuth S, van der Merwe J, Yang J, Gapeshina H, Kim C, Grams J, Shi B, Wille H, Balachandran A, Schmitt-Ulms G, Safar JG, Millhauser GL, Westaway D (2015) Octarepeat region flexibility impacts prion function, endoproteolysis and disease manifestation. EMBO Mol Med 7:339\u2013356","journal-title":"EMBO Mol Med"},{"key":"3582_CR125","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Laur\u00e9n","year":"2009","unstructured":"Laur\u00e9n J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457:1128\u20131132","journal-title":"Nature"},{"key":"3582_CR126","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ebiom.2019.07.036","volume":"46","author":"D Le Corre","year":"2019","unstructured":"Le Corre D, Ghazi A, Balogoun R, Pilati C, Aparicio T, Martin-Lanner\u00e9e S, Marisa L, Djouadi F, Poindessous V, Crozet C, Emile J-F, Mulot C, Le Malicot K, Boige V, Blons H, de Reynies A, Taieb J, Ghiringhelli F, Bennouna J, Launay J-M, Laurent-Puig P, Mouillet-Richard S (2019) The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer. EBioMedicine 46:94\u2013104","journal-title":"EBioMedicine"},{"key":"3582_CR127","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1471-4159.2012.07913.x","volume":"124","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Baskakov IV (2013) The cellular form of the prion protein is involved in controlling cell cycle dynamics, self-renewal, and the fate of human embryonic stem cell differentiation. J Neurochem 124:310\u2013322","journal-title":"J Neurochem"},{"key":"3582_CR128","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/19336896.2020.1854034","volume":"14","author":"G Legname","year":"2020","unstructured":"Legname G, Scial\u00f2 C (2020) On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases. Prion 14:257\u2013270","journal-title":"Prion"},{"key":"3582_CR129","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/sj.embor.embor768","volume":"4","author":"C Leucht","year":"2003","unstructured":"Leucht C, Simoneau S, Rey C, Vana K, Rieger R, Lasm\u00e9zas CI, Weiss S (2003) The 37 kDa\/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep 4:290\u2013295","journal-title":"EMBO Rep"},{"key":"3582_CR130","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/NEN.0b013e3181b96981","volume":"68","author":"V Lewis","year":"2009","unstructured":"Lewis V, Hill AF, Haigh CL, Klug GM, Masters CL, Lawson VA, Collins SJ (2009) Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection. J Neuropathol Exp Neurol 68:1125\u20131135","journal-title":"J Neuropathol Exp Neurol"},{"key":"3582_CR131","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00018-015-2022-z","volume":"73","author":"V Lewis","year":"2016","unstructured":"Lewis V, Johanssen VA, Crouch PJ, Klug GM, Hooper NM, Collins SJ (2016) Prion protein \u201cgamma-cleavage\u201d: characterizing a novel endoproteolytic processing event. Cell Mol Life Sci 73:667\u2013683","journal-title":"Cell Mol Life Sci"},{"key":"3582_CR132","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00018-008-8548-6","volume":"66","author":"Q-Q Li","year":"2009","unstructured":"Li Q-Q, Cao X-X, Xu J-D, Chen Q, Wang W-J, Tang F, Chen Z-Q, Liu X-P, Xu Z-D (2009) The role of P-glycoprotein\/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel. Cell Mol Life Sci 66:504\u2013515","journal-title":"Cell Mol Life Sci"},{"key":"3582_CR133","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4161\/pri.22511","volume":"6","author":"J Liang","year":"2012","unstructured":"Liang J, Kong Q (2012) \u03b1-Cleavage of cellular prion protein. Prion 6:453\u2013460","journal-title":"Prion"},{"key":"3582_CR134","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1096\/fj.06-7799com","volume":"21","author":"J Liang","year":"2007","unstructured":"Liang J, Pan Y, Zhang D, Guo C, Shi Y, Wang J, Chen Y, Wang X, Liu J, Guo X, Chen Z, Qiao T, Fan D (2007) Cellular prion protein promotes proliferation and G1\/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J 21:2247\u20132256","journal-title":"FASEB J"},{"key":"3582_CR135","doi-asserted-by":"publisher","first-page":"16510","DOI":"10.1074\/jbc.M112.360891","volume":"287","author":"J Liang","year":"2012","unstructured":"Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, Surewicz WK, Booth SA, Kong Q (2012) Cellular prion protein regulates its own \u03b1-cleavage through ADAM8 in skeletal muscle. J Biol Chem 287:16510\u201316520","journal-title":"J Biol Chem"},{"key":"3582_CR136","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2017.00077","volume":"10","author":"R Linden","year":"2017","unstructured":"Linden R (2017) The biological function of the prion protein: a cell surface scaffold of signaling modules. Front Mol Neurosci 10:77","journal-title":"Front Mol Neurosci"},{"key":"3582_CR137","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.bbamcr.2017.06.022","volume":"1864","author":"L Linsenmeier","year":"2017","unstructured":"Linsenmeier L, Altmeppen HC, Wetzel S, Mohammadi B, Saftig P, Glatzel M (2017) Diverse functions of the prion protein \u2014 does proteolytic processing hold the key? Biochim Biophys Acta Mol Cell Res 1864:2128\u20132137","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3582_CR138","doi-asserted-by":"publisher","first-page":"eabj1826","DOI":"10.1126\/sciadv.abj1826","volume":"7","author":"L Linsenmeier","year":"2021","unstructured":"Linsenmeier L, Mohammadi B, Shafiq M, Frontzek K, B\u00e4r J, Shrivastava AN, Damme M, Song F, Schwarz A, Da Vela S, Massignan T, Jung S, Correia A, Schmitz M, Puig B, Hornemann S, Zerr I, Tatzelt J, Biasini E, Saftig P, Schweizer M, Svergun D, Amin L, Mazzola F, Varani L, Thapa S, Gilch S, Sch\u00e4tzl H, Harris DA, Triller A, Mikhaylova M, Aguzzi A, Altmeppen HC, Glatzel M (2021) Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies. Sci Adv 7:eabj1826","journal-title":"Sci Adv"},{"key":"3582_CR139","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-018-0248-6","volume":"13","author":"L Linsenmeier","year":"2018","unstructured":"Linsenmeier L, Mohammadi B, Wetzel S, Puig B, Jackson WS, Hartmann A, Uchiyama K, Sakaguchi S, Endres K, Tatzelt J, Saftig P, Glatzel M, Altmeppen HC (2018) Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein. Mol Neurodegener 13:18","journal-title":"Mol Neurodegener"},{"key":"3582_CR140","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1038\/onc.2014.261","volume":"34","author":"MH Lopes","year":"2015","unstructured":"Lopes MH, Santos TG, Rodrigues BR, Queiroz-Hazarbassanov N, Cunha IW, Wasilewska-Sampaio AP, Costa-Silva B, Marchi FA, Bleggi-Torres LF, Sanematsu PI, Suzuki SH, Oba-Shinjo SM, Marie SKN, Toulmin E, Hill AF, Martins VR (2015) Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival. Oncogene 34:3305\u20133314","journal-title":"Oncogene"},{"key":"3582_CR141","doi-asserted-by":"publisher","first-page":"71630","DOI":"10.18632\/oncotarget.17795","volume":"8","author":"G Luo","year":"2017","unstructured":"Luo G, Wang W, Wu Q, Lu Y, Su T, Gu N, Li K, Wang J, Du R, Zhao X, Li X, Fan R, Zhang H, Nie Y, Zhou X, Shi Y, Liang J, Wang X, Fan D (2017) MGr1-Antigen\/37 kDa laminin receptor precursor promotes cellular prion protein induced multi-drug-resistance of gastric cancer. Oncotarget 8:71630\u201371641","journal-title":"Oncotarget"},{"key":"3582_CR142","first-page":"4382","volume":"130","author":"N Makarava","year":"2020","unstructured":"Makarava N, Chang JC-Y, Molesworth K, Baskakov IV (2020) Posttranslational modifications define course of prion strain adaptation and disease phenotype. J Clin Invest 130:4382\u20134395","journal-title":"J Clin Invest"},{"key":"3582_CR143","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1371\/journal.pbio.1000055","volume":"7","author":"E M\u00e1laga-Trillo","year":"2009","unstructured":"M\u00e1laga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L, Thomanetz V, Stuermer CAO (2009) Regulation of embryonic cell adhesion by the prion protein. PLoS Biol 7:e55","journal-title":"PLoS Biol"},{"key":"3582_CR144","doi-asserted-by":"publisher","first-page":"16343","DOI":"10.1523\/JNEUROSCI.1984-10.2010","volume":"30","author":"M Malinverno","year":"2010","unstructured":"Malinverno M, Carta M, Epis R, Marcello E, Verpelli C, Cattabeni F, Sala C, Mulle C, Di Luca M, Gardoni F (2010) Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage. J Neurosci 30:16343\u201316355","journal-title":"J Neurosci"},{"key":"3582_CR145","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biolcel.2003.11.007","volume":"96","author":"A Mang\u00e9","year":"2004","unstructured":"Mang\u00e9 A, B\u00e9ranger F, Peoc\u2019h K, Onodera T, Frobert Y, Lehmann S (2004) Alpha- and beta- cleavages of the amino-terminus of the cellular prion protein. Biol Cell 96:125\u2013132","journal-title":"Biol Cell"},{"key":"3582_CR146","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0014-5793(02)02338-4","volume":"514","author":"A Mang\u00e9","year":"2002","unstructured":"Mang\u00e9 A, Milhavet O, Umlauf D, Harris D, Lehmann S (2002) PrP-dependent cell adhesion in N2a neuroblastoma cells. FEBS Lett 514:159\u2013162","journal-title":"FEBS Lett"},{"key":"3582_CR147","doi-asserted-by":"publisher","first-page":"w20222","DOI":"10.4414\/smw.2020.20222","volume":"150","author":"G Manni","year":"2020","unstructured":"Manni G, Lewis V, Senesi M, Spagnolli G, Fallarino F, Collins SJ, Mouillet-Richard S, Biasini E (2020) The cellular prion protein beyond prion diseases. Swiss Med Wkly 150:w20222","journal-title":"Swiss Med Wkly"},{"key":"3582_CR148","first-page":"331","volume":"3","author":"JC Manson","year":"1994","unstructured":"Manson JC, Clarke AR, McBride PA, McConnell I, Hope J (1994) PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3:331\u2013340","journal-title":"Neurodegeneration"},{"key":"3582_CR149","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1074\/jbc.RA120.013779","volume":"295","author":"E Mantuano","year":"2020","unstructured":"Mantuano E, Azmoon P, Banki MA, Lam MS, Sigurdson CJ, Gonias SL (2020) A soluble derivative of PrPC activates cell-signaling and regulates cell physiology through LRP1 and the NMDA receptor. J Biol Chem 295:14178\u201314188","journal-title":"J Biol Chem"},{"key":"3582_CR150","doi-asserted-by":"publisher","first-page":"25457","DOI":"10.1074\/jbc.M203248200","volume":"277","author":"M Marella","year":"2002","unstructured":"Marella M, Lehmann S, Grassi J, Chabry J (2002) Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J Biol Chem 277:25457\u201325464","journal-title":"J Biol Chem"},{"key":"3582_CR151","doi-asserted-by":"publisher","DOI":"10.3791\/59282","author":"S Martellucci","year":"2019","unstructured":"Martellucci S, Santacroce C, Manganelli V, Santilli F, Piccoli L, Cassetta M, Misasi R, Sorice M, Mattei V (2019a) Isolation, propagation, and prion protein expression during neuronal differentiation of human dental pulp stem cells. J vis Exp. https:\/\/doi.org\/10.3791\/59282","journal-title":"J vis Exp"},{"key":"3582_CR152","doi-asserted-by":"publisher","first-page":"E345","DOI":"10.3390\/ijms20020345","volume":"20","author":"S Martellucci","year":"2019","unstructured":"Martellucci S, Santacroce C, Santilli F, Piccoli L, Delle Monache S, Angelucci A, Misasi R, Sorice M, Mattei V (2019b) Cellular and Molecular Mechanisms Mediated by recPrPC Involved in the Neuronal Differentiation Process of Mesenchymal Stem Cells. Int J Mol Sci 20:E345","journal-title":"Int J Mol Sci"},{"key":"3582_CR153","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/jnc.14891","volume":"152","author":"V Mattei","year":"2020","unstructured":"Mattei V, Manganelli V, Martellucci S, Capozzi A, Mantuano E, Longo A, Ferri A, Garofalo T, Sorice M, Misasi R (2020) A multimolecular signaling complex including PrPC and LRP1 is strictly dependent on lipid rafts and is essential for the function of tissue plasminogen activator. J Neurochem 152:468\u2013481","journal-title":"J Neurochem"},{"key":"3582_CR154","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1042\/BST20160290","volume":"45","author":"AL Matthews","year":"2017","unstructured":"Matthews AL, Szyroka J, Collier R, Noy PJ, Tomlinson MG (2017) Scissor sisters: regulation of ADAM10 by the TspanC8 tetraspanins. Biochem Soc Trans 45:719\u2013730","journal-title":"Biochem Soc Trans"},{"key":"3582_CR155","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/febs.12654","volume":"281","author":"CE Mays","year":"2014","unstructured":"Mays CE, Coomaraswamy J, Watts JC, Yang J, Ko KWS, Strome B, Mercer RCC, Wohlgemuth SL, Schmitt-Ulms G, Westaway D (2014) Endoproteolytic processing of the mammalian prion glycoprotein family. FEBS J 281:862\u2013876","journal-title":"FEBS J"},{"key":"3582_CR156","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1074\/jbc.M113.502351","volume":"289","author":"AJ McDonald","year":"2014","unstructured":"McDonald AJ, Dibble JP, Evans EGB, Millhauser GL (2014) A new paradigm for enzymatic control of \u03b1-cleavage and \u03b2-cleavage of the prion protein. J Biol Chem 289:803\u2013813","journal-title":"J Biol Chem"},{"key":"3582_CR157","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0002-9440(10)63291-9","volume":"165","author":"NF McLennan","year":"2004","unstructured":"McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, Ritchie D, Brannan F, Head MW, Ironside JW, Williams A, Bell JE (2004) Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 165:227\u2013235","journal-title":"Am J Pathol"},{"key":"3582_CR158","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1074\/jbc.M007243200","volume":"276","author":"HE McMahon","year":"2001","unstructured":"McMahon HE, Mang\u00e9 A, Nishida N, Cr\u00e9minon C, Casanova D, Lehmann S (2001) Cleavage of the amino terminus of the prion protein by reactive oxygen species. J Biol Chem 276:2286\u20132291","journal-title":"J Biol Chem"},{"key":"3582_CR159","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11481-013-9458-4","volume":"8","author":"B Megra","year":"2013","unstructured":"Megra B, Eugenin E, Roberts T, Morgello S, Berman JW (2013) Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND. J Neuroimmune Pharmacol 8:1159\u20131166","journal-title":"J Neuroimmune Pharmacol"},{"key":"3582_CR160","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4049\/jimmunol.1601041","volume":"199","author":"BW Megra","year":"2017","unstructured":"Megra BW, Eugenin EA, Berman JW (2017) The role of Shed PrPc in the neuropathogenesis of HIV infection. J Immunol 199:224\u2013232","journal-title":"J Immunol"},{"key":"3582_CR161","doi-asserted-by":"publisher","first-page":"e0133741","DOI":"10.1371\/journal.pone.0133741","volume":"10","author":"M Mehrabian","year":"2015","unstructured":"Mehrabian M, Brethour D, Wang H, Xi Z, Rogaeva E, Schmitt-Ulms G (2015) The prion protein controls polysialylation of neural cell adhesion molecule 1 during cellular morphogenesis. PLoS One 10:e0133741","journal-title":"PLoS ONE"},{"key":"3582_CR162","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0092-8674(03)00201-0","volume":"113","author":"P Meier","year":"2003","unstructured":"Meier P, Genoud N, Prinz M, Maissen M, R\u00fclicke T, Zurbriggen A, Raeber AJ, Aguzzi A (2003) Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Cell 113:49\u201360","journal-title":"Cell"},{"key":"3582_CR163","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1007\/s12035-019-1505-6","volume":"56","author":"E Meneghetti","year":"2019","unstructured":"Meneghetti E, Gasperini L, Virgilio T, Moda F, Tagliavini F, Benetti F, Legname G (2019) Prions strongly reduce NMDA receptor S-nitrosylation levels at pre-symptomatic and terminal stages of prion diseases. Mol Neurobiol 56:6035\u20136045","journal-title":"Mol Neurobiol"},{"key":"3582_CR164","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1074\/mcp.RA119.001702","volume":"18","author":"EV Minikel","year":"2019","unstructured":"Minikel EV, Kuhn E, Cocco AR, Vallabh SM, Hartigan CR, Reidenbach AG, Safar JG, Raymond GJ, McCarthy MD, O\u2019Keefe R, Llorens F, Zerr I, Capellari S, Parchi P, Schreiber SL, Carr SA (2019) Domain-specific quantification of prion protein in cerebrospinal fluid by targeted mass spectrometry. Mol Cell Proteomics 18:2388\u20132400","journal-title":"Mol Cell Proteomics"},{"key":"3582_CR165","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1093\/nar\/gkaa616","volume":"48","author":"EV Minikel","year":"2020","unstructured":"Minikel EV, Zhao HT, Le J, O\u2019Moore J, Pitstick R, Graffam S, Carlson GA, Kavanaugh MP, Kriz J, Kim JB, Ma J, Wille H, Aiken J, McKenzie D, Doh-Ura K, Beck M, O\u2019Keefe R, Stathopoulos J, Caron T, Schreiber SL, Carroll JB, Kordasiewicz HB, Cabin DE, Vallabh SM (2020) Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints. Nucleic Acids Res 48:10615\u201310631","journal-title":"Nucleic Acids Res"},{"key":"3582_CR166","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/jnr.21142","volume":"85","author":"N Mitsios","year":"2007","unstructured":"Mitsios N, Saka M, Krupinski J, Pennucci R, Sanfeliu C, Miguel Turu M, Gaffney J, Kumar P, Kumar S, Sullivan M, Slevin M (2007) Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J Neurosci Res 85:602\u2013611","journal-title":"J Neurosci Res"},{"key":"3582_CR167","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.4103\/1673-5374.301008","volume":"16","author":"B Mohammadi","year":"2021","unstructured":"Mohammadi B, Glatzel M, Altmeppen HC (2021) Disordered structure and flexible roles: using the prion protein N1 fragment for neuroprotective and regenerative therapy. Neural Regen Res 16:1431\u20131432","journal-title":"Neural Regen Res"},{"key":"3582_CR168","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1007\/s12035-020-01917-2","volume":"57","author":"B Mohammadi","year":"2020","unstructured":"Mohammadi B, Linsenmeier L, Shafiq M, Puig B, Galliciotti G, Giudici C, Willem M, Eden T, Koch-Nolte F, Lin Y-H, Tatzelt J, Glatzel M, Altmeppen HC (2020) Transgenic overexpression of the disordered prion protein N1 fragment in mice does not protect against neurodegenerative diseases due to impaired ER translocation. Mol Neurobiol 57:2812\u20132829","journal-title":"Mol Neurobiol"},{"key":"3582_CR169","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.3201\/eid2212.160635","volume":"22","author":"SJ Moore","year":"2016","unstructured":"Moore SJ, Kunkle R, Greenlee MHW, Nicholson E, Richt J, Hamir A, Waters WR, Greenlee J (2016) Horizontal transmission of chronic wasting disease in reindeer. Emerg Infect Dis 22:2142\u20132145","journal-title":"Emerg Infect Dis"},{"key":"3582_CR170","doi-asserted-by":"publisher","first-page":"a024448","DOI":"10.1101\/cshperspect.a024448","volume":"8","author":"JA Moreno","year":"2018","unstructured":"Moreno JA, Telling GC (2018) Molecular mechanisms of chronic wasting disease prion propagation. Cold Spring Harb Perspect Med 8:a024448","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3582_CR171","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1126\/science.289.5486.1925","volume":"289","author":"S Mouillet-Richard","year":"2000","unstructured":"Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O (2000) Signal transduction through prion protein. Science 289:1925\u20131928","journal-title":"Science"},{"key":"3582_CR172","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/ncomms3416","volume":"4","author":"AJ Nicoll","year":"2013","unstructured":"Nicoll AJ, Panico S, Freir DB, Wright D, Terry C, Risse E, Herron CE, O\u2019Malley T, Wadsworth JDF, Farrow MA, Walsh DM, Saibil HR, Collinge J (2013) Amyloid-\u03b2 nanotubes are associated with prion protein-dependent synaptotoxicity. Nat Commun 4:2416","journal-title":"Nat Commun"},{"key":"3582_CR173","doi-asserted-by":"publisher","first-page":"33104","DOI":"10.1074\/jbc.C112.400614","volume":"287","author":"K Nieznanski","year":"2012","unstructured":"Nieznanski K, Choi J-K, Chen S, Surewicz K, Surewicz WK (2012) Soluble prion protein inhibits amyloid-\u03b2 (A\u03b2) fibrillization and toxicity. J Biol Chem 287:33104\u201333108","journal-title":"J Biol Chem"},{"key":"3582_CR174","doi-asserted-by":"publisher","first-page":"14129","DOI":"10.1021\/bi061526k","volume":"45","author":"KA Nishina","year":"2006","unstructured":"Nishina KA, Deleault NR, Mahal SP, Baskakov I, Luhrs T, Riek R, Supattapone S (2006) The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. Biochemistry 45:14129\u201314139","journal-title":"Biochemistry"},{"key":"3582_CR175","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1084\/jem.20151610","volume":"213","author":"M Nuvolone","year":"2016","unstructured":"Nuvolone M, Hermann M, Sorce S, Russo G, Tiberi C, Schwarz P, Minikel E, Sanoudou D, Pelczar P, Aguzzi A (2016) Strictly co-isogenic C57BL\/6J-Prnp-\/- mice: a rigorous resource for prion science. J Exp Med 213:313\u2013327","journal-title":"J Exp Med"},{"key":"3582_CR176","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0092-8674(85)90333-2","volume":"40","author":"B Oesch","year":"1985","unstructured":"Oesch B, Westaway D, W\u00e4lchli M, McKinley MP, Kent SB, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE (1985) A cellular gene encodes scrapie PrP 27\u201330 protein. Cell 40:735\u2013746","journal-title":"Cell"},{"key":"3582_CR177","doi-asserted-by":"publisher","first-page":"e9107","DOI":"10.1371\/journal.pone.0009107","volume":"5","author":"JB Oliveira-Martins","year":"2010","unstructured":"Oliveira-Martins JB, Yusa S, Calella AM, Bridel C, Baumann F, Dametto P, Aguzzi A (2010) Unexpected tolerance of alpha-cleavage of the prion protein to sequence variations. PLoS One 5:e9107","journal-title":"PLoS ONE"},{"key":"3582_CR178","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.1523\/JNEUROSCI.1700-18.2018","volume":"38","author":"T Ondrejcak","year":"2018","unstructured":"Ondrejcak T, Klyubin I, Corbett GT, Fraser G, Hong W, Mably AJ, Gardener M, Hammersley J, Perkinton MS, Billinton A, Walsh DM, Rowan MJ (2018) Cellular prion protein mediates the disruption of hippocampal synaptic plasticity by soluble tau in vivo. J Neurosci 38:10595\u201310606","journal-title":"J Neurosci"},{"key":"3582_CR179","doi-asserted-by":"publisher","first-page":"eaai8288","DOI":"10.1126\/scisignal.aai8288","volume":"10","author":"C Ostalecki","year":"2017","unstructured":"Ostalecki C, Lee J-H, Dindorf J, Collenburg L, Schierer S, Simon B, Schliep S, Kremmer E, Schuler G, Baur AS (2017) Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytes. Sci Signal 10:eaai8288","journal-title":"Sci Signal"},{"key":"3582_CR180","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/jnc.12296","volume":"127","author":"VG Ostapchenko","year":"2013","unstructured":"Ostapchenko VG, Beraldo FH, Guimar\u00e3es ALS, Mishra S, Guzman M, Fan J, Martins VR, Prado VF, Prado MAM (2013) Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer\u2019s disease. J Neurochem 127:415\u2013425","journal-title":"J Neurochem"},{"key":"3582_CR181","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.4049\/jimmunol.1301019","volume":"191","author":"CJ Padro","year":"2013","unstructured":"Padro CJ, Shawler TM, Gormley MG, Sanders VM (2013) Adrenergic regulation of IgE involves modulation of CD23 and ADAM10 expression on exosomes. J Immunol 191:5383\u20135397","journal-title":"J Immunol"},{"key":"3582_CR182","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1096\/fj.06-6138fje","volume":"20","author":"Y Pan","year":"2006","unstructured":"Pan Y, Zhao L, Liang J, Liu J, Shi Y, Liu N, Zhang G, Jin H, Gao J, Xie H, Wang J, Liu Z, Fan D (2006) Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 20:1886\u20131888","journal-title":"FASEB J"},{"key":"3582_CR183","doi-asserted-by":"publisher","first-page":"44627","DOI":"10.1074\/jbc.M107458200","volume":"276","author":"P Parizek","year":"2001","unstructured":"Parizek P, Roeckl C, Weber J, Flechsig E, Aguzzi A, Raeber AJ (2001) Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells. J Biol Chem 276:44627\u201344632","journal-title":"J Biol Chem"},{"key":"3582_CR184","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1242\/jcs.021816","volume":"121","author":"CJ Parkyn","year":"2008","unstructured":"Parkyn CJ, Vermeulen EGM, Mootoosamy RC, Sunyach C, Jacobsen C, Oxvig C, Moestrup S, Liu Q, Bu G, Jen A, Morris RJ (2008) LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J Cell Sci 121:773\u2013783","journal-title":"J Cell Sci"},{"key":"3582_CR185","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35089090","volume":"412","author":"D Peretz","year":"2001","unstructured":"Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412:739\u2013743","journal-title":"Nature"},{"key":"3582_CR186","doi-asserted-by":"publisher","first-page":"12922","DOI":"10.1096\/fj.202000823R","volume":"34","author":"R P\u00e9rez-Gonz\u00e1lez","year":"2020","unstructured":"P\u00e9rez-Gonz\u00e1lez R, Kim Y, Miller C, Pacheco-Quinto J, Eckman EA, Levy E (2020) Extracellular vesicles: where the amyloid precursor protein carboxyl-terminal fragments accumulate and amyloid-\u03b2 oligomerizes. FASEB J 34:12922\u201312931","journal-title":"FASEB J"},{"key":"3582_CR187","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1006\/bbrc.1996.0936","volume":"223","author":"F Perini","year":"1996","unstructured":"Perini F, Vidal R, Ghetti B, Tagliavini F, Frangione B, Prelli F (1996) PrP27-30 is a normal soluble prion protein fragment released by human platelets. Biochem Biophys Res Commun 223:572\u2013577","journal-title":"Biochem Biophys Res Commun"},{"key":"3582_CR188","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/02699052.2021.1900602","volume":"35","author":"A Persad","year":"2021","unstructured":"Persad A, Pham N, Moien-Afshari F, Gormley W, Yan S, Mannix R, Taghibiglou C (2021) Plasma PrPC and ADAM-10 as novel biomarkers for traumatic brain injury and concussion: a pilot study. Brain Inj 35:734\u2013741","journal-title":"Brain Inj"},{"key":"3582_CR189","doi-asserted-by":"publisher","first-page":"e24377","DOI":"10.4161\/tisb.24377","volume":"1","author":"CSV Petit","year":"2013","unstructured":"Petit CSV, Besnier L, Morel E, Rousset M, Thenet S (2013) Roles of the cellular prion protein in the regulation of cell-cell junctions and barrier function. Tissue Barriers 1:e24377","journal-title":"Tissue Barriers"},{"key":"3582_CR190","doi-asserted-by":"publisher","first-page":"e34691","DOI":"10.1371\/journal.pone.0034691","volume":"7","author":"A Petit-Paitel","year":"2012","unstructured":"Petit-Paitel A, M\u00e9nard B, Guyon A, B\u00e9ringue V, Nahon J-L, Zs\u00fcrger N, Chabry J (2012) Prion protein is a key determinant of alcohol sensitivity through the modulation of N-methyl-D-aspartate receptor (NMDAR) activity. PLoS One 7:e34691","journal-title":"PLoS ONE"},{"key":"3582_CR191","doi-asserted-by":"publisher","first-page":"e0117286","DOI":"10.1371\/journal.pone.0117286","volume":"10","author":"N Pham","year":"2015","unstructured":"Pham N, Akonasu H, Shishkin R, Taghibiglou C (2015a) Plasma soluble prion protein, a potential biomarker for sport-related concussions: a pilot study. PLoS One 10:e0117286","journal-title":"PLoS ONE"},{"key":"3582_CR192","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/neu.2014.3471","volume":"32","author":"N Pham","year":"2015","unstructured":"Pham N, Sawyer TW, Wang Y, Jazii FR, Vair C, Taghibiglou C (2015b) Primary blast-induced traumatic brain injury in rats leads to increased prion protein in plasma: a potential biomarker for blast-induced traumatic brain injury. J Neurotrauma 32:58\u201365","journal-title":"J Neurotrauma"},{"key":"3582_CR193","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.3302","volume":"19","author":"M Pietri","year":"2013","unstructured":"Pietri M, Dakowski C, Hannaoui S, Alleaume-Butaux A, Hernandez-Rapp J, Ragagnin A, Mouillet-Richard S, Haik S, Bailly Y, Peyrin J-M, Launay J-M, Kellermann O, Schneider B (2013) PDK1 decreases TACE-mediated \u03b1-secretase activity and promotes disease progression in prion and Alzheimer\u2019s diseases. Nat Med 19:1124\u20131131","journal-title":"Nat Med"},{"key":"3582_CR194","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3233\/JAD-150482","volume":"49","author":"EC Pinnock","year":"2016","unstructured":"Pinnock EC, Jovanovic K, Pinto MG, Ferreira E, Dias BDC, Penny C, Knackmuss S, Reusch U, Little M, Schatzl HM, Weiss SFT (2016) LRP\/LR antibody mediated rescuing of amyloid-\u03b2-induced cytotoxicity is dependent on PrPc in Alzheimer\u2019s disease. J Alzheimers Dis 49:645\u2013657","journal-title":"J Alzheimers Dis"},{"key":"3582_CR195","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1126\/science.3277272","volume":"239","author":"RW Price","year":"1988","unstructured":"Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586\u2013592","journal-title":"Science"},{"key":"3582_CR196","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1128\/jvi.68.8.4873-4878.1994","volume":"68","author":"SA Priola","year":"1994","unstructured":"Priola SA, Caughey B, Race RE, Chesebro B (1994) Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 68:4873\u20134878","journal-title":"J Virol"},{"key":"3582_CR197","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1093\/emboj\/20.23.6692","volume":"20","author":"SA Priola","year":"2001","unstructured":"Priola SA, Lawson VA (2001) Glycosylation influences cross-species formation of protease-resistant prion protein. EMBO J 20:6692\u20136699","journal-title":"EMBO J"},{"key":"3582_CR198","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/stem.1663","volume":"32","author":"K Prodromidou","year":"2014","unstructured":"Prodromidou K, Papastefanaki F, Sklaviadis T, Matsas R (2014) Functional cross-talk between the cellular prion protein and the neural cell adhesion molecule is critical for neuronal differentiation of neural stem\/precursor cells. Stem Cells 32:1674\u20131687","journal-title":"Stem Cells"},{"key":"3582_CR199","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1038\/onc.2017.200","volume":"36","author":"L Provenzano","year":"2017","unstructured":"Provenzano L, Ryan Y, Hilton DA, Lyons-Rimmer J, Dave F, Maze EA, Adams CL, Rigby-Jones R, Ammoun S, Hanemann CO (2017) Cellular prion protein (PrPC) in the development of Merlin-deficient tumours. Oncogene 36:6132\u20136142","journal-title":"Oncogene"},{"key":"3582_CR200","doi-asserted-by":"publisher","first-page":"12915","DOI":"10.1523\/JNEUROSCI.5910-12.2013","volume":"33","author":"J Prox","year":"2013","unstructured":"Prox J, Bernreuther C, Altmeppen H, Grendel J, Glatzel M, D\u2019Hooge R, Stroobants S, Ahmed T, Balschun D, Willem M, Lammich S, Isbrandt D, Schweizer M, Horr\u00e9 K, De Strooper B, Saftig P (2013) Postnatal disruption of the disintegrin\/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci 33:12915\u201312928","journal-title":"J Neurosci"},{"key":"3582_CR201","first-page":"31","volume":"80","author":"SB Prusiner","year":"1993","unstructured":"Prusiner SB (1993) Prion encephalopathies of animals and humans. Dev Biol Stand 80:31\u201344","journal-title":"Dev Biol Stand"},{"key":"3582_CR202","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136\u2013144","journal-title":"Science"},{"key":"3582_CR203","doi-asserted-by":"publisher","first-page":"e1007520","DOI":"10.1371\/journal.ppat.1007520","volume":"15","author":"B Puig","year":"2019","unstructured":"Puig B, Altmeppen HC, Linsenmeier L, Chakroun K, Wegwitz F, Piontek UK, Tatzelt J, Bate C, Magnus T, Glatzel M (2019) GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice. PLoS Pathog 15:e1007520","journal-title":"PLoS Pathog"},{"key":"3582_CR204","doi-asserted-by":"publisher","first-page":"e24624","DOI":"10.1371\/journal.pone.0024624","volume":"6","author":"B Puig","year":"2011","unstructured":"Puig B, Altmeppen HC, Thurm D, Geissen M, Conrad C, Braulke T, Glatzel M (2011) N-glycans and glycosylphosphatidylinositol-anchor act on polarized sorting of mouse PrP(C) in Madin-Darby canine kidney cells. PLoS One 6:e24624","journal-title":"PLoS ONE"},{"key":"3582_CR205","doi-asserted-by":"publisher","first-page":"24970","DOI":"10.1038\/srep24970","volume":"6","author":"B Puig","year":"2016","unstructured":"Puig B, Altmeppen HC, Ulbrich S, Linsenmeier L, Krasemann S, Chakroun K, Acevedo-Morantes CY, Wille H, Tatzelt J, Glatzel M (2016) Secretory pathway retention of mutant prion protein induces p38-MAPK activation and lethal disease in mice. Sci Rep 6:24970","journal-title":"Sci Rep"},{"key":"3582_CR206","doi-asserted-by":"publisher","first-page":"E1609","DOI":"10.3390\/cells9071609","volume":"9","author":"B Puig","year":"2020","unstructured":"Puig B, Yang D, Brenna S, Altmeppen HC, Magnus T (2020) Show me your friends and I tell you who you are: The many facets of prion protein in stroke. Cells 9:E1609","journal-title":"Cells"},{"key":"3582_CR207","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.expneurol.2009.03.017","volume":"217","author":"B Race","year":"2009","unstructured":"Race B, Meade-White K, Race R, Baumann F, Aguzzi A, Chesebro B (2009) Prion protein on astrocytes or in extracellular fluid impedes neurodegeneration induced by truncated prion protein. Exp Neurol 217:347\u2013352","journal-title":"Exp Neurol"},{"key":"3582_CR208","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2051-5960-1-25","volume":"1","author":"A Rangel","year":"2013","unstructured":"Rangel A, Race B, Klingeborn M, Striebel J, Chesebro B (2013) Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein. Acta Neuropathol Commun 1:25","journal-title":"Acta Neuropathol Commun"},{"key":"3582_CR209","doi-asserted-by":"publisher","first-page":"131175","DOI":"10.1172\/jci.insight.131175","volume":"5","author":"GJ Raymond","year":"2019","unstructured":"Raymond GJ, Zhao HT, Race B, Raymond LD, Williams K, Swayze EE, Graffam S, Le J, Caron T, Stathopoulos J, O\u2019Keefe R, Lubke LL, Reidenbach AG, Kraus A, Schreiber SL, Mazur C, Cabin DE, Carroll JB, Minikel EV, Kordasiewicz H, Caughey B, Vallabh SM (2019) Antisense oligonucleotides extend survival of prion-infected mice. JCI Insight 5:131175","journal-title":"JCI Insight"},{"key":"3582_CR210","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/emboj.2011.86","volume":"30","author":"UK Resenberger","year":"2011","unstructured":"Resenberger UK, Harmeier A, Woerner AC, Goodman JL, M\u00fcller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, Multhaup G, Winklhofer KF, Tatzelt J (2011) The cellular prion protein mediates neurotoxic signalling of \u03b2-sheet-rich conformers independent of prion replication. EMBO J 30:2057\u20132070","journal-title":"EMBO J"},{"key":"3582_CR211","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/bjh.12543","volume":"163","author":"AJ Ritchie","year":"2013","unstructured":"Ritchie AJ, Crawford DM, Ferguson DJP, Burthem J, Roberts DJ (2013) Normal prion protein is expressed on exosomes isolated from human plasma. Br J Haematol 163:678\u2013680","journal-title":"Br J Haematol"},{"key":"3582_CR212","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.2353\/ajpath.2010.091006","volume":"177","author":"TK Roberts","year":"2010","unstructured":"Roberts TK, Eugenin EA, Morgello S, Clements JE, Zink MC, Berman JW (2010) PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am J Pathol 177:1848\u20131860","journal-title":"Am J Pathol"},{"key":"3582_CR213","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1073\/pnas.90.8.3182","volume":"90","author":"M Rogers","year":"1993","unstructured":"Rogers M, Yehiely F, Scott M, Prusiner SB (1993) Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc Natl Acad Sci U S A 90:3182\u20133186","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR214","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.cdd.4401629","volume":"12","author":"X Roucou","year":"2005","unstructured":"Roucou X, Giannopoulos PN, Zhang Y, Jodoin J, Goodyer CG, LeBlanc A (2005) Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ 12:783\u2013795","journal-title":"Cell Death Differ"},{"key":"3582_CR215","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40478-017-0435-7","volume":"5","author":"R Rubenstein","year":"2017","unstructured":"Rubenstein R, Chang B, Grinkina N, Drummond E, Davies P, Ruditzky M, Sharma D, Wang K, Wisniewski T (2017) Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein. Acta Neuropathol Commun 5:30","journal-title":"Acta Neuropathol Commun"},{"key":"3582_CR216","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1074\/jbc.M112.400358","volume":"288","author":"JV Rushworth","year":"2013","unstructured":"Rushworth JV, Griffiths HH, Watt NT, Hooper NM (2013) Prion protein-mediated toxicity of amyloid-\u03b2 oligomers requires lipid rafts and the transmembrane LRP1. J Biol Chem 288:8935\u20138951","journal-title":"J Biol Chem"},{"key":"3582_CR217","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.10.003","volume":"135","author":"P Saftig","year":"2015","unstructured":"Saftig P, Lichtenthaler SF (2015) The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain. Prog Neurobiol 135:1\u201320","journal-title":"Prog Neurobiol"},{"key":"3582_CR218","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1042\/BST20160296","volume":"45","author":"J Saint-Pol","year":"2017","unstructured":"Saint-Pol J, Eschenbrenner E, Dornier E, Boucheix C, Charrin S, Rubinstein E (2017) Regulation of the trafficking and the function of the metalloprotease ADAM10 by tetraspanins. Biochem Soc Trans 45:937\u2013944","journal-title":"Biochem Soc Trans"},{"key":"3582_CR219","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.1523\/JNEUROSCI.0722-17.2017","volume":"37","author":"SV Salazar","year":"2017","unstructured":"Salazar SV, Gallardo C, Kaufman AC, Herber CS, Haas LT, Robinson S, Manson JC, Lee MK, Strittmatter SM (2017) Conditional deletion of Prnp rescues behavioral and synaptic deficits after disease onset in transgenic Alzheimer\u2019s disease. J Neurosci 37:9207\u20139221","journal-title":"J Neurosci"},{"key":"3582_CR220","doi-asserted-by":"publisher","first-page":"104335","DOI":"10.1016\/j.neuint.2018.11.010","volume":"130","author":"\u00d8 Salvesen","year":"2019","unstructured":"Salvesen \u00d8, Tatzelt J, Tranulis MA (2019) The prion protein in neuroimmune crosstalk. Neurochem Int 130:104335","journal-title":"Neurochem Int"},{"key":"3582_CR221","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature09768","volume":"470","author":"MK Sandberg","year":"2011","unstructured":"Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470:540\u2013542","journal-title":"Nature"},{"key":"3582_CR222","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1083\/jcb.200409127","volume":"169","author":"A Santuccione","year":"2005","unstructured":"Santuccione A, Sytnyk V, Leshchyns\u2019ka I, Schachner M (2005) Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 169:341\u2013354","journal-title":"J Cell Biol"},{"key":"3582_CR223","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1006\/jmbi.2000.5183","volume":"314","author":"G Schmitt-Ulms","year":"2001","unstructured":"Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, Prusiner SB (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314:1209\u20131225","journal-title":"J Mol Biol"},{"key":"3582_CR224","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.neurobiolaging.2004.10.004","volume":"26","author":"K Schwarze-Eicker","year":"2005","unstructured":"Schwarze-Eicker K, Keyvani K, G\u00f6rtz N, Westaway D, Sachser N, Paulus W (2005) Prion protein (PrPc) promotes beta-amyloid plaque formation. Neurobiol Aging 26:1177\u20131182","journal-title":"Neurobiol Aging"},{"key":"3582_CR225","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.nbd.2016.03.001","volume":"91","author":"JJ Scott-McKean","year":"2016","unstructured":"Scott-McKean JJ, Surewicz K, Choi J-K, Ruffin VA, Salameh AI, Nieznanski K, Costa ACS, Surewicz WK (2016) Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by A\u03b2 oligomers: Implications for novel therapeutic strategy in Alzheimer\u2019s disease. Neurobiol Dis 91:124\u2013131","journal-title":"Neurobiol Dis"},{"key":"3582_CR226","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1007\/s00018-018-2791-2","volume":"75","author":"L Seipold","year":"2018","unstructured":"Seipold L, Altmeppen H, Koudelka T, Tholey A, Kasparek P, Sedlacek R, Schweizer M, B\u00e4r J, Mikhaylova M, Glatzel M, Saftig P (2018) In vivo regulation of the A disintegrin and metalloproteinase 10 (ADAM10) by the tetraspanin 15. Cell Mol Life Sci 75:3251\u20133267","journal-title":"Cell Mol Life Sci"},{"key":"3582_CR227","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1089\/neu.2018.5918","volume":"36","author":"S Sekar","year":"2019","unstructured":"Sekar S, Zhang Y, Miranzadeh Mahabadi H, Parvizi A, Taghibiglou C (2019) Low-field magnetic stimulation restores cognitive and motor functions in the mouse model of repeated traumatic brain injury: role of cellular prion protein. J Neurotrauma 36:3103\u20133114","journal-title":"J Neurotrauma"},{"key":"3582_CR228","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1172\/JCI131564","volume":"130","author":"AM Sevillano","year":"2020","unstructured":"Sevillano AM, Aguilar-Calvo P, Kurt TD, Lawrence JA, Soldau K, Nam TH, Schumann T, Pizzo DP, Nystr\u00f6m S, Choudhury B, Altmeppen H, Esko JD, Glatzel M, Nilsson KPR, Sigurdson CJ (2020) Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease. J Clin Invest 130:1350\u20131362","journal-title":"J Clin Invest"},{"key":"3582_CR229","doi-asserted-by":"publisher","first-page":"15922","DOI":"10.1016\/S0021-9258(18)82340-7","volume":"268","author":"SL Shyng","year":"1993","unstructured":"Shyng SL, Huber MT, Harris DA (1993) A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 268:15922\u201315928","journal-title":"J Biol Chem"},{"key":"3582_CR230","doi-asserted-by":"publisher","first-page":"8967","DOI":"10.1523\/JNEUROSCI.1115-05.2005","volume":"25","author":"W-C Shyu","year":"2005","unstructured":"Shyu W-C, Lin S-Z, Chiang M-F, Ding D-C, Li K-W, Chen S-F, Yang H-I, Li H (2005) Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci 25:8967\u20138977","journal-title":"J Neurosci"},{"key":"3582_CR231","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1515\/BC.2003.027","volume":"384","author":"S Simoneau","year":"2003","unstructured":"Simoneau S, Ha\u00efk S, Leucht C, Dormont D, Deslys J-P, Weiss S, Lasm\u00e9zas C (2003) Different isoforms of the non-integrin laminin receptor are present in mouse brain and bind PrP. Biol Chem 384:243\u2013246","journal-title":"Biol Chem"},{"key":"3582_CR232","doi-asserted-by":"publisher","first-page":"21857","DOI":"10.1074\/jbc.M116.743435","volume":"291","author":"U Slap\u0161ak","year":"2016","unstructured":"Slap\u0161ak U, Salzano G, Amin L, Abskharon RNN, Ilc G, Zupan\u010di\u010d B, Biljan I, Plavec J, Giachin G, Legname G (2016) The N terminus of the prion protein mediates functional interactions with the neuronal cell adhesion molecule (NCAM) fibronectin domain. J Biol Chem 291:21857\u201321868","journal-title":"J Biol Chem"},{"key":"3582_CR233","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fimmu.2020.00499","volume":"11","author":"TM Smith","year":"2020","unstructured":"Smith TM, Tharakan A, Martin RK (2020) Targeting ADAM10 in cancer and autoimmunity. Front Immunol 11:499","journal-title":"Front Immunol"},{"key":"3582_CR234","doi-asserted-by":"publisher","first-page":"e70327","DOI":"10.1371\/journal.pone.0070327","volume":"8","author":"GP Solis","year":"2013","unstructured":"Solis GP, Radon Y, Sempou E, Jechow K, Stuermer CAO, M\u00e1laga-Trillo E (2013) Conserved roles of the prion protein domains on subcellular localization and cell-cell adhesion. PLoS One 8:e70327","journal-title":"PLoS ONE"},{"key":"3582_CR235","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.nbd.2005.04.002","volume":"20","author":"A Spudich","year":"2005","unstructured":"Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, Bassetti CL, Hermann DM (2005) Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1\/-2 and STAT-1. Neurobiol Dis 20:442\u2013449","journal-title":"Neurobiol Dis"},{"key":"3582_CR236","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0092-8674(87)90150-4","volume":"51","author":"N Stahl","year":"1987","unstructured":"Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229\u2013240","journal-title":"Cell"},{"key":"3582_CR237","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1021\/bi00474a028","volume":"29","author":"N Stahl","year":"1990","unstructured":"Stahl N, Borchelt DR, Prusiner SB (1990) Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry 29:5405\u20135412","journal-title":"Biochemistry"},{"key":"3582_CR238","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1073\/pnas.0511290103","volume":"103","author":"AD Steele","year":"2006","unstructured":"Steele AD, Emsley JG, Ozdinler PH, Lindquist S, Macklis JD (2006) Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci U S A 103:3416\u20133421","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR239","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1042\/BJ20051013","volume":"393","author":"A Stoeck","year":"2006","unstructured":"Stoeck A, Keller S, Riedle S, Sanderson MP, Runz S, Le Naour F, Gutwein P, Ludwig A, Rubinstein E, Altevogt P (2006) A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J 393:609\u2013618","journal-title":"Biochem J"},{"key":"3582_CR240","doi-asserted-by":"publisher","first-page":"21223","DOI":"10.1073\/pnas.1117827108","volume":"108","author":"J St\u00f6hr","year":"2011","unstructured":"St\u00f6hr J, Watts JC, Legname G, Oehler A, Lemus A, Nguyen H-OB, Sussman J, Wille H, DeArmond SJ, Prusiner SB, Giles K (2011) Spontaneous generation of anchorless prions in transgenic mice. Proc Natl Acad Sci U S A 108:21223\u201321228","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR241","doi-asserted-by":"publisher","first-page":"59181","DOI":"10.18632\/oncotarget.19469","volume":"8","author":"L Sun","year":"2017","unstructured":"Sun L, Zhao M, Zhang J, Liu A, Ji W, Li Y, Yang X, Wu Z (2017) MiR-144 promotes \u03b2-amyloid accumulation-induced cognitive impairments by targeting ADAM10 following traumatic brain injury. Oncotarget 8:59181\u201359203","journal-title":"Oncotarget"},{"key":"3582_CR242","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1074\/jbc.M609663200","volume":"282","author":"C Sunyach","year":"2007","unstructured":"Sunyach C, Cisse MA, da Costa CA, Vincent B, Checler F (2007) The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation. J Biol Chem 282:1956\u20131963","journal-title":"J Biol Chem"},{"key":"3582_CR243","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/S0006-291X(05)80038-5","volume":"184","author":"F Tagliavini","year":"1992","unstructured":"Tagliavini F, Prelli F, Porro M, Salmona M, Bugiani O, Frangione B (1992) A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun 184:1398\u20131404","journal-title":"Biochem Biophys Res Commun"},{"key":"3582_CR244","doi-asserted-by":"publisher","first-page":"e12941","DOI":"10.1111\/bpa.12941","volume":"31","author":"RH Takahashi","year":"2021","unstructured":"Takahashi RH, Yokotsuka M, Tobiume M, Sato Y, Hasegawa H, Nagao T, Gouras GK (2021) Accumulation of cellular prion protein within \u03b2-amyloid oligomer plaques in aged human brains. Brain Pathol 31:e12941","journal-title":"Brain Pathol"},{"key":"3582_CR245","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1083\/jcb.129.1.121","volume":"129","author":"A Taraboulos","year":"1995","unstructured":"Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB, Avraham D (1995) Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 129:121\u2013132","journal-title":"J Cell Biol"},{"key":"3582_CR246","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1042\/BJ20061736","volume":"402","author":"DR Taylor","year":"2007","unstructured":"Taylor DR, Hooper NM (2007) The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem J 402:17\u201323","journal-title":"Biochem J"},{"key":"3582_CR247","doi-asserted-by":"publisher","first-page":"22590","DOI":"10.1074\/jbc.M109.032599","volume":"284","author":"DR Taylor","year":"2009","unstructured":"Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, Hooper NM (2009) Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 284:22590\u201322600","journal-title":"J Biol Chem"},{"key":"3582_CR248","doi-asserted-by":"publisher","first-page":"e0227094","DOI":"10.1371\/journal.pone.0227094","volume":"15","author":"JM Tennant","year":"2020","unstructured":"Tennant JM, Li M, Henderson DM, Tyer ML, Denkers ND, Haley NJ, Mathiason CK, Hoover EA (2020) Shedding and stability of CWD prion seeding activity in cervid feces. PLoS One 15:e0227094","journal-title":"PLoS ONE"},{"key":"3582_CR249","doi-asserted-by":"publisher","first-page":"E1458","DOI":"10.3390\/cells8111458","volume":"8","author":"S Thellung","year":"2019","unstructured":"Thellung S, Corsaro A, Bosio AG, Zambito M, Barbieri F, Mazzanti M, Florio T (2019) Emerging role of cellular prion protein in the maintenance and expansion of glioma stem cells. Cells 8:E1458","journal-title":"Cells"},{"key":"3582_CR250","doi-asserted-by":"publisher","first-page":"25497","DOI":"10.1074\/jbc.M114.566588","volume":"289","author":"CR Trevitt","year":"2014","unstructured":"Trevitt CR, Hosszu LLP, Batchelor M, Panico S, Terry C, Nicoll AJ, Risse E, Taylor WA, Sandberg MK, Al-Doujaily H, Linehan JM, Saibil HR, Scott DJ, Collinge J, Waltho JP, Clarke AR (2014) N-terminal domain of prion protein directs its oligomeric association. J Biol Chem 289:25497\u201325508","journal-title":"J Biol Chem"},{"key":"3582_CR251","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1523\/JNEUROSCI.1103-12.2012","volume":"32","author":"JA Turnbaugh","year":"2012","unstructured":"Turnbaugh JA, Unterberger U, Sa\u00e1 P, Massignan T, Fluharty BR, Bowman FP, Miller MB, Supattapone S, Biasini E, Harris DA (2012) The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc). J Neurosci 32:8817\u20138830","journal-title":"J Neurosci"},{"key":"3582_CR252","doi-asserted-by":"publisher","first-page":"e25675","DOI":"10.1371\/journal.pone.0025675","volume":"6","author":"JA Turnbaugh","year":"2011","unstructured":"Turnbaugh JA, Westergard L, Unterberger U, Biasini E, Harris DA (2011) The N-terminal, polybasic region is critical for prion protein neuroprotective activity. PLoS One 6:e25675","journal-title":"PLoS ONE"},{"key":"3582_CR253","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.2741\/3169","volume":"13","author":"M Turu","year":"2008","unstructured":"Turu M, Slevin M, Ethirajan P, Luque A, Elasbali A, Font A, Gaffney J, Cairols M, Kumar P, Kumar S, Krupinski J (2008) The normal cellular prion protein and its possible role in angiogenesis. Front Biosci 13:6491\u20136500","journal-title":"Front Biosci"},{"key":"3582_CR254","doi-asserted-by":"publisher","first-page":"e1006470","DOI":"10.1371\/journal.ppat.1006470","volume":"13","author":"K Uchiyama","year":"2017","unstructured":"Uchiyama K, Tomita M, Yano M, Chida J, Hara H, Das NR, Nykjaer A, Sakaguchi S (2017) Prions amplify through degradation of the VPS10P sorting receptor sortilin. PLoS Pathog 13:e1006470","journal-title":"PLoS Pathog"},{"key":"3582_CR255","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","volume":"79","author":"JW Um","year":"2013","unstructured":"Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, Kerrisk ME, Vortmeyer A, Wisniewski T, Koleske AJ, Gunther EC, Nygaard HB, Strittmatter SM (2013) Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer a\u03b2 oligomer bound to cellular prion protein. Neuron 79:887\u2013902","journal-title":"Neuron"},{"key":"3582_CR256","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM (2012) Alzheimer amyloid-\u03b2 oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15:1227\u20131235","journal-title":"Nat Neurosci"},{"key":"3582_CR257","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1073\/pnas.1901947116","volume":"116","author":"SM Vallabh","year":"2019","unstructured":"Vallabh SM, Nobuhara CK, Llorens F, Zerr I, Parchi P, Capellari S, Kuhn E, Klickstein J, Safar JG, Nery FC, Swoboda KJ, Geschwind MD, Zetterberg H, Arnold SE, Minikel EV, Schreiber SL (2019) Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development. Proc Natl Acad Sci U S A 116:7793\u20137798","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR258","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/13543776.2019.1693543","volume":"29","author":"L Vania","year":"2019","unstructured":"Vania L, Morris G, Otgaar TC, Bignoux MJ, Bernert M, Burns J, Gabathuse A, Singh E, Ferreira E, Weiss SFT (2019) Patented therapeutic approaches targeting LRP\/LR for cancer treatment. Expert Opin Ther Pat 29:987\u20131009","journal-title":"Expert Opin Ther Pat"},{"key":"3582_CR259","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.vetimm.2008.04.002","volume":"124","author":"LJ Vella","year":"2008","unstructured":"Vella LJ, Greenwood DLV, Cappai R, Scheerlinck J-PY, Hill AF (2008) Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. Vet Immunol Immunopathol 124:385\u2013393","journal-title":"Vet Immunol Immunopathol"},{"key":"3582_CR260","doi-asserted-by":"publisher","first-page":"37743","DOI":"10.1074\/jbc.M105677200","volume":"276","author":"B Vincent","year":"2001","unstructured":"Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E, Checler F (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 276:37743\u201337746","journal-title":"J Biol Chem"},{"key":"3582_CR261","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1016\/j.ajpath.2016.07.010","volume":"186","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yu S, Huang D, Cui M, Hu H, Zhang L, Wang W, Parameswaran N, Jackson M, Osborne B, Bedogni B, Li C, Sy M-S, Xin W, Zhou L (2016) Cellular prion protein mediates pancreatic cancer cell survival and invasion through association with and enhanced signaling of Notch1. Am J Pathol 186:2945\u20132956","journal-title":"Am J Pathol"},{"key":"3582_CR262","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1089\/neu.2012.2383","volume":"29","author":"KM Warren","year":"2012","unstructured":"Warren KM, Reeves TM, Phillips LL (2012) MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury. J Neurotrauma 29:1922\u20131940","journal-title":"J Neurotrauma"},{"key":"3582_CR263","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-017-1790-y","volume":"135","author":"JC Watts","year":"2018","unstructured":"Watts JC, Bourkas MEC, Arshad H (2018) The function of the cellular prion protein in health and disease. Acta Neuropathol 135:159\u2013178","journal-title":"Acta Neuropathol"},{"key":"3582_CR264","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neulet.2004.09.030","volume":"372","author":"J Weise","year":"2004","unstructured":"Weise J, Crome O, Sandau R, Schulz-Schaeffer W, B\u00e4hr M, Zerr I (2004) Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett 372:146\u2013150","journal-title":"Neurosci Lett"},{"key":"3582_CR265","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/01.STR.0000217262.03192.d4","volume":"37","author":"J Weise","year":"2006","unstructured":"Weise J, Sandau R, Schwarting S, Crome O, Wrede A, Schulz-Schaeffer W, Zerr I, B\u00e4hr M (2006) Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 37:1296\u20131300","journal-title":"Stroke"},{"key":"3582_CR266","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/nar\/14.5.2035","volume":"14","author":"D Westaway","year":"1986","unstructured":"Westaway D, Prusiner SB (1986) Conservation of the cellular gene encoding the scrapie prion protein. Nucleic Acids Res 14:2035\u20132044","journal-title":"Nucleic Acids Res"},{"key":"3582_CR267","doi-asserted-by":"publisher","first-page":"44234","DOI":"10.1074\/jbc.M111.286195","volume":"286","author":"L Westergard","year":"2011","unstructured":"Westergard L, Turnbaugh JA, Harris DA (2011) A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation. J Biol Chem 286:44234\u201344242","journal-title":"J Biol Chem"},{"key":"3582_CR268","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.bbamcr.2017.06.005","volume":"1864","author":"S Wetzel","year":"2017","unstructured":"Wetzel S, Seipold L, Saftig P (2017) The metalloproteinase ADAM10: A useful therapeutic target? Biochim Biophys Acta Mol Cell Res 1864:2071\u20132081","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3582_CR269","first-page":"124092","volume":"5","author":"AP Wiegmans","year":"2019","unstructured":"Wiegmans AP, Saunus JM, Ham S, Lobb R, Kutasovic JR, Dalley AJ, Miranda M, Atkinson C, Foliaki ST, Ferguson K, Niland C, Johnstone CN, Lewis V, Collins SJ, Lakhani SR, Al-Ejeh F, M\u00f6ller A (2019) Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer. JCI Insight 5:124092","journal-title":"JCI Insight"},{"key":"3582_CR270","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4161\/pri.22588","volume":"6","author":"L Wik","year":"2012","unstructured":"Wik L, Klingeborn M, Willander H, Linne T (2012) Separate mechanisms act concurrently to shed and release the prion protein from the cell. Prion 6:498\u2013509","journal-title":"Prion"},{"key":"3582_CR271","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12915-017-0375-5","volume":"15","author":"M-A Wulf","year":"2017","unstructured":"Wulf M-A, Senatore A, Aguzzi A (2017) The biological function of the cellular prion protein: an update. BMC Biol 15:34","journal-title":"BMC Biol"},{"key":"3582_CR272","doi-asserted-by":"publisher","first-page":"e58786","DOI":"10.1371\/journal.pone.0058786","volume":"8","author":"X Xiao","year":"2013","unstructured":"Xiao X, Yuan J, Ha\u00efk S, Cali I, Zhan Y, Moudjou M, Li B, Laplanche J-L, Laude H, Langeveld J, Gambetti P, Kitamoto T, Kong Q, Brandel J-P, Cobb BA, Petersen RB, Zou W-Q (2013) Glycoform-selective prion formation in sporadic and familial forms of prion disease. PLoS One 8:e58786","journal-title":"PLoS ONE"},{"key":"3582_CR273","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/CBI20110088","volume":"36","author":"YH-Y Yap","year":"2012","unstructured":"Yap YH-Y, Say Y-H (2012) Resistance against tumour necrosis factor \u03b1 apoptosis by the cellular prion protein is cell-specific for oral, colon and kidney cancer cell lines. Cell Biol Int 36:273\u2013277","journal-title":"Cell Biol Int"},{"key":"3582_CR274","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/biom11060784","volume":"11","author":"S Yoon","year":"2021","unstructured":"Yoon S, Go G, Yoon Y, Lim J, Lee G, Lee S (2021) Harnessing the physiological functions of cellular prion protein in the kidneys: applications for treating renal diseases. Biomolecules 11:784","journal-title":"Biomolecules"},{"key":"3582_CR275","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1073\/pnas.1110789109","volume":"109","author":"H You","year":"2012","unstructured":"You H, Tsutsui S, Hameed S, Kannanayakal TJ, Chen L, Xia P, Engbers JDT, Lipton SA, Stys PK, Zamponi GW (2012) A\u03b2 neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 109:1737\u20131742","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR276","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1038\/srep02911","volume":"3","author":"J Yuan","year":"2013","unstructured":"Yuan J, Zhan Y-A, Abskharon R, Xiao X, Martinez MC, Zhou X, Kneale G, Mikol J, Lehmann S, Surewicz WK, Castilla J, Steyaert J, Zhang S, Kong Q, Petersen RB, Wohlkonig A, Zou W-Q (2013) Recombinant human prion protein inhibits prion propagation in vitro. Sci Rep 3:2911","journal-title":"Sci Rep"},{"key":"3582_CR277","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1074\/jbc.M113.531335","volume":"289","author":"G Zanusso","year":"2014","unstructured":"Zanusso G, Fiorini M, Ferrari S, Meade-White K, Barbieri I, Brocchi E, Ghetti B, Monaco S (2014) Gerstmann-Str\u00e4ussler-Scheinker disease and \u201canchorless prion protein\u201d mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease. J Biol Chem 289:4870\u20134881","journal-title":"J Biol Chem"},{"key":"3582_CR278","doi-asserted-by":"publisher","first-page":"e0136923","DOI":"10.1371\/journal.pone.0136923","volume":"10","author":"B Zhang","year":"2015","unstructured":"Zhang B, Cowden D, Zhang F, Yuan J, Siedlak S, Abouelsaad M, Zeng L, Zhou X, O\u2019Toole J, Das AS, Kofskey D, Warren M, Bian Z, Cui Y, Tan T, Kresak A, Wyza RE, Petersen RB, Wang G-X, Kong Q, Wang X, Sedor J, Zhu X, Zhu H, Zou W-Q (2015) Prion protein protects against renal ischemia\/reperfusion injury. PLoS One 10:e0136923","journal-title":"PLoS ONE"},{"key":"3582_CR279","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1073\/pnas.0510577103","volume":"103","author":"CC Zhang","year":"2006","unstructured":"Zhang CC, Steele AD, Lindquist S, Lodish HF (2006) Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc Natl Acad Sci U S A 103:2184\u20132189","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3582_CR280","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2010.10.001","volume":"41","author":"O Zohar","year":"2011","unstructured":"Zohar O, Lavy R, Zi X, Nelson TJ, Hongpaisan J, Pick CG, Alkon DL (2011) PKC activator therapeutic for mild traumatic brain injury in mice. Neurobiol Dis 41:329\u2013337","journal-title":"Neurobiol Dis"}],"container-title":["Cell and Tissue Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-022-03582-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00441-022-03582-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-022-03582-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T10:33:36Z","timestamp":1726569216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00441-022-03582-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":280,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["3582"],"URL":"https:\/\/doi.org\/10.1007\/s00441-022-03582-4","relation":{},"ISSN":["0302-766X","1432-0878"],"issn-type":[{"value":"0302-766X","type":"print"},{"value":"1432-0878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animal experiments or research on human subjects\/samples\/cells have been performed for this review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}